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Abstract 
 
Diabetes mellitus is amongst the leading causes of morbidity and mortality in the world, affecting 
young, adult and old people. Beta cell replacement therapy for insulin delivery remains the ultimate 
remedy for diabetes. However, insufficient donor pancreas and the use of immunosuppressive drugs 
prevent the wide-spread of this therapy. Other avenues of self generated beta cells within the organ 
itself need to be explored. Therefore, understanding the chronobiology of cellular mechanisms in 
the lineage of beta cell induced neogenesis is a valuable tool in improving beta cell replacement in 
patients with diabetes. The aim of this study was to induce recapitulation of the morpho-genetic 
sequence of endocrine cells development in the pancreas of rats after the pancreatic duct ligation 
(PDL) procedure. Serial sections of PDL tissues of the pancreas were obtained from 78 Sprague-
Dawley rats and were assessed morphologically. The immunofluorescent tissues were statistically 
analysed using a computerized morphometry technique. The protein expression indices of 
Caspase3, Insulin, Pdx1, Ngn3, NeuroD and Pax6 were quantified. The efficiency levels of co-
expression of these homeodomain proteins separately with insulin were defined by the ratio of the 
mean value of insulin expression to the mean value of their respective protein expression. The 
morphological changes were characterized by the appearance of granulated acinar cells at 6 hours 
post-PDL and the proliferation of endocrine tissues from 84 hours through to 120 hours. The 
morpho-immunofluorescent evaluation showed the highest immunoreactivity of Caspase3 and Pdx1 
at 6 hours, Ngn3 at 36 hours, Pax6 and insulin at 84 hours while NeuroD expression was at 120 
hours. The immunohistofluorescent analysis showed that caspase3 and Pdx1 were the first to be 
expressed at 6 hours while the insulin and NeuroD expression appeared later at 84 hours and 120 
hours, respectively. However, Pax6 expression was continuous across time periods post-PDL, while 
Ngn3 expression showed a peak at 36 hours. The efficiency (highest and earliest expression) of co-
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expression of all these homeodomain proteins with insulin was restricted between 12 hours and 24 
hours. The optimal efficiency was at 12 hours by Ngn3 with insulin. A good efficiency was shown 
for Pdx1 with insulin, NeuroD with insulin and Pax6 with insulin at 12 hours and 24 hours, 
respectively. A low efficiency was observed for insulin and caspase3 co-expression at 24 hours. 
This study suggests that for transplantation, PDL tissues harvested at an early time post-PDL 
(between 12 and 24 hours) could yield a higher success rate; the study also provides evidence for a 
connection between morphological changes in the PDL pancreas and the protein synthesis 
necessary for the lineage of endocrine cell development.  
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Opsomming 
 
Diabetes Mellitus resorteer onder die vernaamste oorsake van morbiditeit en mortaliteit wêreldwyd, 
en tuister jongmense, volwassenes en bejaardes.  Daar bestaan egter ‘n wêreldwye tekort aan 
skenkerorgane met immuun-onderdrukingsterapie as ondersteuningsbehandeling.  Beta-sel 
vervangingsterapie, vir die voorsiening van insulien, bly daarom die voorkeur behandeling vir die 
siekte wat noodsaak dat die wetenskap kyk na alternatiewe behandelingsregimens wat meganismes 
rondom orgaanregenerasie insluit.   Begrip van die chronobiologie van die sellulêre meganismes 
betrokke rondom beta-sel ontwikkeling mag  waardevolle lig werp op die neogenese van beta-selle 
wat gevolglik daartoe mag lei dat beta-sel vervanging as ‘n moontlike behandelingsterapie oorweeg 
mag word vir pasiënte met suikersiekte.  Die oogmerk van hierdie studie is om die rekapitulasie van 
die morfo-genetiese volgorde van die endokriene pankreas na afbinding van die pankreasbuis te 
bepaal.   Pankreasbuis afbinding is op 78 Sprague-Dawley laboratorium rotte onder algemene 
narkose uitgevoer, die pankreas is na voorafbepaalde tydsvakke verwyder en in histologiese 
seriesnitte gesny. Snitte is immunositochemiese gekleur en morfometries assesseer.   Die 
afskeidingsindeks vir selboodskappers vir Caspase3, Insulien, Pdx1, Ngn3, NeuroD en Pax6 is 
kwantifiseer.    Die gelyktydige afskeiding van elk van bogenoemde boodskappers tesame met 
insulien is omskryf as ‘n verhouding tot mekaar en in terme van dié van insulien.  Die morfologiese 
verandering in die weefsel bespeur is gekenmerk deur die verskyn van gegranuleerde asinêre selle 
ses (6) ure na buisafbinding en die proliferasie van endokriene weefsel vanaf vier-en-tagtig (84) ure 
deurlopend tot een-honderd-en-twintig (120) ure.  Die morfo-immunofluoresserende evaluering 
toon dat Caspase3 en Pdx1 by 6 uur die hoogste is, die van Ngn3 by 36 ure, Pax6 en insulien by 84 
ure en NeuroD by 120 ure.  Verder toon die analise dat Caspase3 en Pdx1  rondom 6 ure hul 
verskyning gemaak het terwyl  dié van insulien en NeuroD eers rondom 84 tot 120 uur verskyn het.   
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Die verskyning van Pax6 het deurlopend regoor al die tydsduurtes verskyn en Ngn3 het rondom 36 
uur sy hoogste vlak bereik.  Die gelyktydige uitdrukking van homeodomein proteïene tesame met 
insulien het slegs tussen die tydperke van 12 en 24 ure plaasgevind.  Die uitdrukking van  Pdx1 met 
insulien, NeuroD met insulien en Pax6 met insulien het almal tussen 12 en 24 ure plaasgevind.  
Caspase3 tesame met insulien is slegs by die 24 uur tydsperiode bespeur.  Vir die oorplant van 
pankreas weefsel wat aan buisafbinding onderwerp is suggereer hierdie studie dat die geskikste tyd 
vir die oes van endokriene weefsel liewer vroeër (12 to 24 ure) as later uitgevoer behoort te word.  
Verder wil dit voorkom of hierdie tydsperiode ook die hoogste seltelling lewer.   Die studie lewer 
waardevolle inligting oor die verwantskap tussen die morfologiese veranderings wat na 
buisafbinding plaasvind en die proteïen sintese wat sel-opvolgontwikkeling bevorder. 
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Chapter 1.  Introduction 
 
 
1.1.      Literature Review 
1.1.1.       Historical background of the pancreas 
 
The name "pancreas" meaning, "all flesh" was attributed to the organ by Ruphos of 
Ephesus an anatomist / surgeon in the first or second Century AD; the same name was 
given to the organ four hundred years earlier when Herophilus, also a Greek anatomist 
and surgeon (born in 336 BC) described the pancreas for the first time; he is said to be 
the Father of Scientific Anatomy (Fitzgerald 1980; Howard and Hess 2002). 
 
The pancreas was thought to serve as a protection and support to the large blood 
vessels lying immediately posterior to it, so Galen (Claudius Galenus 138-201 AD) 
believed. For being the "Physician to the Gladiators" of Rome, as well as to the 
Roman Emperor, Galen’s incorrect assumption held back enthusiastic scientific 
investigators until the eighteenth century. Andreas Vesalius (1514-1564) was the first 
who fairly described the pancreas as “glandulous organ” (Fitzgerald 1980; Singer 
1957). However, Thomas Wharton (1610-1673) who was a prosector noted the 
similarity between the thyroid gland and the pancreas and confirmed the early 
description by Vesalius (Mettler 1947).  
 
Although the pancreas was described and named, its function and microscopic 
features remained a mystery. Serious study of the pancreas commenced with the 
discovery of the pancreatic duct by a German émigré in 1642, Johann George 
Wirsüng. Wirsüng however was not aware of the function of the duct; 
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he posed the question, "Is it an artery or a vein, I have never seen blood in it". His 
colleague later named it "The Duct of Wirsüng" (Howard and Hess 2002). At the 
same time, Franciscus de le Boe (also called Sylvius) suspected that the duct served as 
the passage for the secreted juice into the intestine (Busnardo et al. 1983). In 1742 
Santorini mentioned the accessory duct in its illustration that carried its name 
(Fitzgerald 1980). Meckel however, is presented as the person who first described a 
comprehensive embryology of the pancreas in 1806 (Brunschwig 1942). 
 
Claude Bernard (1813-1875) first described the function of the pancreas in digestion, 
and is considered as the “father of experimental medicine in the artificial production 
of disease by means of chemical and physical manipulation” (Garrison 1929). In 
1852, D. Moyse first described the histology of the pancreas in his thesis; although 
crudely drawn, the pancreas depicted the structure of exocrine acini. Laguesse first 
called the “islet of Langerhans” island of Langerhans in 1893, following the first 
description of the pancreatic islet by Paul Langerhans ("Junior") in collaboration with 
Professor Rudolph Virchow in 1869. The description by Langerhans was the first 
good histological description of the endocrine pancreas (Whipple 1960).  
 
All these discoveries led to a fascinating era in the history of the pancreas in the 19th 
Century. Frederick Grant Banting (1891-1941) and Charles Herbert Best (1899-1978) 
discovered insulin, the first islet cell hormone to be described. In 1921 and later again 
in 1958 Frederick Sanger (b. 1918) of England, determined the molecular structure of 
insulin (Howard and Hess 2002).  
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A disturbance in the islet microanatomy as well as any disruption in the beta cell mass 
balance may impair pancreatic islet function (Bernard et al. 1999) leading to the 
pathogenesis of diabetes. The disease known as diabetes mellitus (DM), however (a 
name given by Aretaeus who lived in Asia Minor (ca A.D. 81-150) described 
overabundant urine (polyuria), unquenchable thirst (polydypsia), a sweet-tasting urine 
(glucosuria), weight loss or even death, as the clinical symptoms of DM.  
 
Allen O. Whipple (1881-1963) is known as the "Father of Pancreatic Surgery”. The 
first human pancreatic transplant of the modern era was performed by a surgical team 
led by Dr. Kelly on December 17, 1966 at the University of Minneapolis. The patient 
who was a 28-year-old female with uncontrolled diabetes and renal failure received a 
cadaveric kidney and pancreas. The grafts functioned for almost two months (Howard 
and Hess 2002; Kelly 1967). 
 
1.1.2.  The Morphology of the Pancreas 
1.1.2.1.           The human pancreas 
 
The pancreas is a lobulated gland, similar in structure to the salivary glands, though 
softer and less compactly arranged than those organs; it extends nearly transversely 
across the posterior abdominal wall from the curvature of the duodenum to the spleen, 
posterior to the stomach (Fig. 1) (Gray 1995). 
 
In humans, the pancreas measures between 12.5-25 cm in length and weighs between 
60-150 grams (Gray 1995; Slack 1995). The pancreas consists of the head, neck, tail 
and uncinate processes. The large head joins the body (major part of the gland) on its 
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right; through a constricted neck. The head of the pancreas is flattened 
anteroposteriorly with small portions embedded in the wall of the descending part of 
the duodenum forming the uncinate processes of the pancreas. Both are in close  
contact with the abdominal aorta anteriorly. A groove formed by the anterior 
boundary between head and neck gives room to the gastroduodenal artery.  
 
On the right hand side of the head posteriorly as well as the left hand side of the head, 
the union of the superior mesenteric and splenic veins is contained in a deep incisure  
where forming the origin of the portal vein. The neck of the pancreas forms a forward, 
upward curve to the left from the head, joining with the body. The body has three 
obliquely set surfaces namely, anterior, posterior and inferior. The posterior surface of 
the body is devoid of peritoneum, is in contact with the aorta and is where begin the 
superior mesenteric artery, the left crus of diaphragm, the left suprarenal gland, the 
left kidney and renal veins. The splenic vein runs from the left to the right; forming a 
partition between it and the above mentioned structures. The tail of the pancreas and 
the splenic vessels form the content of the space between the two layers of the 
splenorenal (lienorenal) ligament (Gray 1995).  
 
The lobes of the pancreas are made of lobules from each of which small ducts 
(interlobular ducts) emerge. The interlobular ducts give rise to intralobular ducts 
which in turn become intercalated ducts as they enter the substance of the lobules 
where they lie between the secretory units and the intralobular ducts. Intercalated 
ducts open into the lumen of acinar cells as centroacinar ducts. Most interlobular 
ducts join the main pancreatic duct (duct of Wirsüng) at right angle forming a 
Herring-bone configuration. The main pancreatic duct extends from the tail of the 
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gland to the body and the neck, and increasing in size as many other ductules join 
along its path. The main pancreatic duct lies nearer the posterior surface than the 
anterior surface of the gland. The main pancreatic duct is whitish in colour and it is 
found posterior to the head of pancreas; it first curves downwards then to the right just 
before it joins the common bile duct on its right side. The main pancreatic duct enters 
obliquely into the wall of the descending part of the duodenum, where it unites with 
the common bile duct in a short dilated hepatopancreatic ampulla (ampulla of Vater) 
to open on the major duodenal papilla, which lies posteromedial to the duodenum. 
There is an accessory pancreatic duct (duct of Santorini) which is formed by fusion of  
small ducts from the lower and left portion of the head of the pancreas; it 
communicates with the main duct, and drains the lower part of the head of the 
pancreas, it enters the duodenum at the minor duodenal papilla (Gray 1995). 
 
 
 
Figure 1. The human pancreas as seen in the abdomen (Modified from Slack 1995). 
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1.1.2.2. The rodent pancreas 
 
In rodents the pancreas is diffuse and the shape cannot be well determined (Slack 
1995). It weights between 550 mg (at 100 g-body weight) to 1 g (at 300 g-body 
weight) (Richards et al. 1964). The pancreas is found in the craniodorsal part of the 
abdominal cavity in the rat and could be divided into two parts. The first part is made 
of the body and right lobe; this is embedded in the mesoduodenum and the beginning 
of the mesojejunum. A second part, which is a branched flattened left lobe, is partially 
fused to the ascending colon and blankets the superior mesenteric-portal vein. It then 
runs along the dorsal aspect of the stomach, embedded in the dorsal part of the greater 
omentum, and along the lineal artery toward the intestinal surface of the spleen (Hebel 
and Stromberg 1986).  
 
Figure 2.  The rodent’s pancreas showing a diffuse pattern (Page et al. 2000). 
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Although there are numerous ducts present in rodents, their course differs between 
rats and mice. However, there is no accessory duct present in the rat (Hebel and 
Stromberg 1986). At least two large pancreatic ducts are formed from fusion of fifteen 
to forty excretory ducts. The centroacinar cells form the terminal part of the ductal 
cells (Ekholm et al. 1962). The largest duct (splenic duct) always originates from the 
left lobe. It opens into the common bile duct at the junction of the hepatic duct. The 
remaining duct enters the common bile duct just before the latter enters the duodenum 
(Sun 1987). Sometimes small ducts open directly into the duodenum (Hebel 1969; 
Richards et al. 1964). The hepatic duct is covered along its length by pancreatic tissue 
(Richards et al. 1964).  
 
1.1.2.3. The arterial supply and innervations to the pancreas 
 
The arterial supply to the pancreas comes from two sources, the celiac trunk which 
forms the superior series of supply and, the superior mesenteric artery that gives off 
branches to form the inferior series of supply (Gray 1995). The anastomotic arcades 
between superior and inferior pancreatic arteries create a rich vascular supply around 
the pancreas. In addition to these arcades, there is a free arterial plexus around and  
within the gland; the part within the gland and which is situated in the connective 
tissue between pancreatic lobules is termed the interlobular plexus. From this plexus, 
intralobular vessels pass to the gland parenchyma. A work by Wharton that was later 
confirmed by Fujita and co-worker showed that, each pancreatic lobule is supplied by 
a single intralobular artery that further divides and ends among the cells of the islets 
of Langerhans (Keynes and Keith 1981).   
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Ross et al. (2003) indicated that, in humans the capillaries first perfuse the alpha and 
delta cells, peripherally, before the blood reaches the beta cells, centrally. The insular 
vascular bed is essentially sinusoidal and gives off efferent sinusoids which pass into 
the exocrine components of the lobules and collectively form an interacinar capillary 
plexus. This portal-like circulation (portal system of Fujita) provides the exocrine 
pancreas with islets secretion that directly influences the exocrine function. In mice 
one to three afferent arterioles arise from arterial rami to supply each islet, before 
which they may supply the acini (Bunnag et al. 1963). 
 
The pancreas receives both sympathetic (adrenergic) and parasympathetic 
(cholinergic) innervations via the vagus and the splanchnic nerves respectively, with 
the major innervations for secretory stimulation occurring via the vagus nerves. The 
fibers of these nerves reach the pancreas through periarterial plexuses, but some fibers 
may reach the pancreas directly through independent fibers not associated with 
arteries (Keynes and Keith 1981).  
 
1.1.2.4.       Pancreas development and cytodifferentiation 
 
The pancreas develops from the fusion of two distinct buds, the ventral and dorsal 
pancreatic buds; the two buds emerge as evaginations of the embryonic gut endoderm 
about embryonic day 8.5-9 (Wessells and Cohen 1967). Events that occur in the 
ventral and dorsal pancreatic domains in early development are independent 
(Yoshitomi and Zaret 2004). Serial reciprocal inductions of the endoderm and 
adjacent mesoderm determine the cell fate in both ventral and dorsal buds tissue types 
(Grapin-Botton and Melton 2000). However, the formation and differentiation of all 
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pancreatic cell types (organogenesis) continue in postnatal life until three months of 
age (McEvoy 1981). 
 
Two phases of organogenesis have been identified, namely morphogenesis, which is 
defined as the multicellular structure characteristic of the specific organ, and secondly 
cytodifferentiation which is the expression of the organ specific, differentiated cellular 
phenotype (Gittes and Rutter 1992). 
 
The end of gastrulation corresponds to embryonic day 25 in humans (Liu and Potter 
1962), day 9.5 (e9.5) in mouse (Slack 1995), and day 10 (e10) in the rat (Altman and 
Dittmer 1962). At this stage there are three germ layers present, namely endoderm, 
ectoderm and mesoderm. The endodermal germ layer will give rise to the digestive 
tract and the associated organs, including the pancreas. Pancreatic morphology is 
apparent with the evagination of the dorsal pancreatic bud in the early stage of 
development. In the rat, the notochord loses its connection with the endoderm at e11 
and this is the time when the foregut and hindgut become visible. The dorsal 
pancreatic bud arises as an endodermal evagination from the cluster of cells in the 
caudal part of the foregut at e12. Soon after (e13), the dorsal pancreas will enlarge and 
the ventral pancreatic bud will develop from the hepatic duct. As the duodenum and 
stomach start to rotate, the dorsal and ventral pancreases begin to fuse at e14 
meanwhile the dorsal pancreatic duct (of Santorini) degenerates. By e15, the 
pancreatic anlagen have fused to become one organ with the ventral duct as the main 
pancreatic duct (Hebel and Stromberg 1986). The beginning of the first foetal stage 
and the end of the metamorphosing embryo is marked by e16 (Altman and Dittmer 
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1962). The developing pancreatic epithelium continues growth and proliferation 
throughout foetal life (Slack 1995).  
 
The main duct elongates, secondary ducts form , which branch off, elongate and from 
which further ducts form and branch off . They develop acini at their terminal ends, 
forming the centroacinar duct, and from the walls of the smaller branches, cell clumps 
bud - these are presumptive islets. The islets increase in size through islet cell 
proliferation and through the merging of cell clumps that are close together. On e21, 
the pancreatic islets are separated from the tissue of exocrine pancreas (Hebel and 
Stromberg 1986). 
 
1.1.2.5.             Induction of endocrine development 
 
One of the first steps required for pancreatic development is an inductive interaction 
between the endoderm and mesoderm that directs a cluster of endodermal cells close 
to the mid-foregut junction toward a pancreatic fate (Deutsch et al. 2001; Grapin-
Botton et al. 2000; Hebrok et al. 1998; Kim et al. 1997; Lammert et al. 2001; Wells 
and Melton 2000). In the early rodent embryo, the notochord is embedded in the 
endoderm, and there is close connection between both tissue types in the neural plate. 
At about the 13-20 somite stage (e9 in mouse and e10.5 in rat), the notochord 
separates from the endoderm, and the dorsal aorta lies between the gut and the 
notochord (Slack 1995). This interaction sets up a pre-pattern in the endoderm for the 
pancreas forming regions, although pancreas-specific genes are not turned on at this 
stage.  
 
http://scholar.sun.ac.za
11 
 
A homeobox containing gene in the Antennapedia/Ftz class (Hex) (Crompton et al. 
1992) controls the proliferation rate, and thus the positioning, of the leading edge of 
endoderm cells that grow beyond the cardiogenic mesoderm, during gut tube closure. 
Ventral pancreas specification is thus dictated (Bort et al. 2004). Aortic endothelial 
cells induce the crucial pancreatic transcription factor Ptf1a (an exocrine subunit of 
pancreatic transcription factor 1 - PTF1) in the dorsal pancreatic endoderm; whereas 
the vitelline veins, which are normally adjacent to the emerging ventral pancreatic 
bud, are unnecessary for ventral Ptfla induction or for ventral pancreatic bud initiation 
(Yoshitomi and Zaret 2004).  
 
Subsequent inductive interactions occur between the notochord and the endodermal 
epithelium. These permissive inductions allow the pancreatic buds to emerge and 
continue development. At about e14 in mouse, the first pancreatic-specific genes are 
expressed, including the homeogene Pdx1 (Guz et al. 1995). When the epithelial sheet 
folds up to make a tube, the two lateral regions fuse to form the site where the ventral 
bud will emerge. The middle region forms the dorsal pancreatic bud. The two 
pancreatic buds require interactions with adjacent mesenchyme for further pancreatic 
growth and differentiation. Henceforth, promotion of pancreatic bud development is 
induced by signalling from the embryonic blood vessel cells, a derivative of the 
mesoderm (Lammert et al. 2001). However, signals from the notochord are important 
for development of the dorsal pancreas, whereas signals from the adjacent endothelial 
cells seem to be necessary for the initiation of both dorsal and ventral pancreatic 
development. The dorsal and ventral pancreatic buds start to develop precisely where 
endoderm previously contacted the endothelium (Lammert et al. 2001, 2003; 
Yoshitomi and Zaret 2004).  
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Thomas and co-workers (1998) have identified Hex expression in the anterior 
endoderm cells at e7.0 of mouse gestation and subsequently in the ventral-lateral 
foregut that gives rise to the ventral pancreas and the liver. While, Deutsch and 
colleagues (2001) reported that fibroblast growth factors from the cardiac mesoderm 
were responsible for inducing local expression of hedgehog (hh) family signalling 
molecules in the adjacent gut endoderm that is inhibitory to pancreas but permissive 
to liver development. However, later ectopic expression of sonic hedgehog (Shh) in 
the mouse pancreas has been shown to prevent a proper pancreatic morphogenesis 
(Apelqvist et al. 1997; Dilorio et al. 2002; Hebrok et al. 2000; Kim et al. 1997). 
Specification of the liver and the ventral pancreas occurs simultaneously from the 
same group of ventral foregut cells that express the homeobox gene Prox 1 (Burke 
and Oliver 2002); while development of the liver is dependent on its close proximity 
to the cardiogenic mesoderm (Deutsch et al. 2001; Lammert et al. 2001, 2003). As 
development continues, the stomach and the duodenum rotate anti-clockwise causing 
the two buds to come together to merge forming one organ; meanwhile exocrine and 
endocrine cytodifferentiation proceeds.  
 
A mature mammalian pancreas is an exocrine and endocrine organ. The exocrine 
component comprises approximately 99% of the total pancreatic mass while the 
endocrine component constitutes about 1%. Islets are more numerous in the tail. The 
exocrine component (ductal and acinar) synthesizes and secretes enzymes (amylase, 
carboxypeptidase, lipase, etc.) into the duodenum that are essential for digestion in the 
intestine. Insulin, glucagon, pancreatic polypeptide and somatostatin are hormones 
synthesized and secreted into the blood by the endocrine component of the pancreas 
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(islets of Langerhans) to regulate glucose, lipid, and protein metabolism in the body 
(Ross et al. 2003).  
 
1.1.3.    Microscopic Anatomy of the islets of Langerhans 
 
The islets of Langerhans are clusters of cells found dispersed within the exocrine 
pancreas. The pancreas is composed of two structurally distinct components in 
intimate association with each other. The main mass (exocrine pancreas) is a 
lobulated, branched acinar gland found throughout the organ; within the exocrine 
pancreas, the islets of Langerhans constitute the endocrine pancreas responsible for 
maintaining glucose homeostasis. The islets of Langerhans are small spheroid clusters 
of cells scattered throughout the organ in cell groupings with a combined mass of 
approximately 1-1.5 grams, but their distribution is not uniform in the pancreas in all 
mammals (Massa et al. 1997). A most recent islet study clearly distinguishes human 
islet architecture from that of rodents (Steiner et al. 2010).  
 
The human pancreas contains approximately one million islets of Langerhans whilst 
several hundred are detectable in rodents (Hughes 1956; Slack 1995). The islets 
constitute about 1 to 2% of the volume of the pancreas but are most numerous in the 
tail. Individual islets of Langerhans may contain only a few cells or many hundreds of 
cells. Cells within individual islets are polygonal in shape and are arranged in short, 
irregular cords that are profusely invested with a network of fenestrated capillaries 
and a rich autonomic innervation (Ross et al. 2003).  
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Immunohistochemical studies demonstrated that the islets of Langerhans are 
composed of four cell types designated alpha (or A or A2), beta (or B), delta (or D or 
A1), and PP (or D1 or F) (protein polypeptide) cells, producing glucagon, insulin, 
somatostatin, and pancreatic polypeptide respectively (Alumets et al. 1983). Although 
islet composition differs in dorsal and ventral part of the pancreas, diverging reports 
on the distribution in the cell-type from different regions of the pancreas are 
documented.  Cabrera et al (2006) reported a relatively even distribution in the 
proportion of endocrine cells, while Brissova et al (2005) observed that more beta and 
alpha cells are found in the body, neck and tail; and PP-cells are found in the head 
(Stefan et al. 1982). Insulin secretion and proinsulin biosynthesis induced by glucose 
stimulation are mostly presnt in the dorsal islets (Baetens et al. 1979; Trimble et al. 
1982). In rodents, beta cells constitute approximately 60-80% of the islet cells and 
generally form the core of the islet. The surrounding layer of endocrine cells include 
alpha cells (15-20%), delta-cells (<10%) and PP-cells (<1%) (Cabrera et al. 2006; 
Kim et al. 2009; Quesada et al. 2008), whereas, the adult human islets constitute 
about 50% beta cells, 40% alpha cells, 10% delta cells and fewer PP-cells (Cabrera et 
al 2006; Brissova et al 2005; Miller et al. 2009).  
 
A fifth peptide hormone, namely ghrelin, produced by epsilon cells has been 
identified in the human islet. These ghrelin-producing epsilon cells are thought to 
regulate the food intake and energy balance, and stimulate the increased secretion of 
growth hormone (Slack 1995). However, the location of these cells within the 
endocrine compartment remains questionable (Date et al. 2002; Volante et al. 2002; 
Wierup et al. 2002; Wierup and Sunder 2005). A number of studies were carried out 
to trace the origin of certain hormone producing cells within the islet; so common 
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precursor cells that co-express the various islet hormones are thought to give rise to 
pancreatic endocrine cells (Teitelman et al. 1987). These common islet progenitor 
cells express peptide YY (Upchurch et al. 1994) or neuropeptide Y (Teitelman et al. 
1993). Teitelman et al (1987) reported that embryonic cells found in duct epithelium 
express tyrosine hydroxylase (TH). Herrera (2000) however, through various studies 
using transgenic cell marking analysis, supported a previous work by Jensen et al. 
(2000a), where it was suggested that cells expressing both insulin and glucagon are 
classified as a subgroup of α-cells that could sometimes express insulin; but both α-
producing cells and β-producing cells have different embryonic origin (Herrera 2000; 
Jensen et al. 2000a).  
 
Endocrine cell differentiation at early stage of pancreatic development can be detected 
using specific markers. Somatostatin mRNA is expressed in the mouse gut endoderm 
as early as e7.5-8.5. The expression of glucagon and insulin mRNA are detected at 
e8.5-9 preceding the PP mRNA expression (Gittes and Rutter 1992); however, 
immunoreactivity for either insulin or glucagon revealed scattered endocrine cells and 
can be seen at e9.5 (Gittes and Rutter 1992; Schwitzgebel et al. 2000) while 
immunoreactivity for PP is first detected much later at e18. Amylase 
immunoreactivity can be seen at e10.5-12 after the transcription of amylase and 
carboxypeptidase is detected 2-4 days earlier (Gittes and Rutter 1992; Herrera et al. 
1991). The early endocrine cells are seen in association with the pancreatic ducts, but 
as they mature, the islets of Langerhans together with beta cells become first 
detectable at around e18-19. It is however evident that endocrine cells 
transdifferentiate from ductal epithelium to fully differentiate into insulin producing 
cells (Bonner-Weir et al. 2000). 
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Although numerous markers used to identify pancreatic endocrine multipotent 
precursors have been reported, the most viable is cytokeratin (CK). Cytokeratin is 
specifically for the pancreatic ductal epithelial cells expression (Bouwens et al. 1994). 
Zulewski et al. (2001) postulated that nestin, which is used as a marker for neural 
stem cells, could also be used to identify pancreatic islet stem cells. Findings by 
Selander and Edlund (2002) found nestin to be expressed in the mesenchymal cells of 
the developing pancreas, but not in the pancreatic epithelial cells which is believed to 
represent the pancreatic progenitor cell pool. Ghrelin is another new marker, which 
was initially isolated from the rat stomach as a ligand for the growth hormone 
secretagogue receptor (GHS-R). It was later found to be expressed in the human 
pancreatic islets throughout life (Weirup et al. 2002), but does not express any of the 
hormones present in the islet cells (e.g. insulin, glucagon, somatostatin or PP) and 
thus constitutes a novel set of islet cell types (Wierup and Sundler 2005).  
 
1.1.4.     Beta cell mass and pathogenesis of diabetes 
 
Beta-cell mass is the total number of islet cells, including the newly formed islet cells 
that arise from pre-existing ductal cells or other precursors cells (neogenesis), and, the 
islet cells formed by replication (proliferation) and programmed cell death (apoptosis) 
of existing islet cells (Vinik et al. 2004). The balance between neogenesis, 
proliferation and apoptosis is critical to sustain the integrity of beta cell mass 
(Finegood et al. 1995).  
 
 
 
http://scholar.sun.ac.za
17 
 
1.1.4.1.   Beta cell neogenesis and apoptosis 
 
Neogenesis is the natural regeneration or formation of new cells in response to a total 
or partial loss of a tissue. Apoptosis however, is a pathway of programmed cell death 
(Kerr 1993) during which the body disposes of damaged, unwanted, or unneeded 
cells; this results in cells shrinking and leading to the fragmentation of their DNA. For 
the survival of living species, most cells in the body are in continuous turnover, with 
the average life span depending on the cell type. In the pancreas, beta cell neogenesis 
and replication occurs significantly during foetal life and continues at a reduced rate at 
the neonatal stage of life (Bouwens et al. 1994). An increase in apoptotic index in 
postnatal beta cells has been reported in humans (Kassem et al. 2000), pig (Bock et al. 
2003) and rodents (Scaglia et al. 1997); this shows a direct link between cell death 
and regeneration or formation of new cells.  Newly formed beta cells  take about 30-
40 days to reach their mature and full functional potential (Samikannu and Linn 
2008). A reduction in beta cell replication due for instance to aging, was implicated in 
glucose intolerance (Swenne 1983); hence indicating the correlation that may exist 
between beta cell pathogenesis and the etiology of diabetes.  
 
1.1.4.2. Beta cell pathogenesis and the etiology of diabetes 
 
The significance of the beta cell mass in the pathophysiology of the pancreas has been 
the focus of extensive research (Akirav et al. 2008; Bouwens and Rooman 2005; 
Donath and Halban 2004; Matveyenko and Butler 2008; Weir and Bonner-weir 2004). 
The mass of beta cells is an important tool for the regulatory mechanisms where 
changes can result in a partial or complete deficiency in insulin secretion. However, 
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changes in beta cell function and insulin synthesis are a direct consequence of the 
balance between the degeneration and the proliferation of these cells which are critical 
for the pathophysiology of the pancreas (Rhodes 2005). Beta cell mass loss in the 
pancreas results from an autoimmune disorder induced by T-cells that destroy beta 
cells and cause a lack of insulin production, thereby suppressing signaling responses 
that trigger cellular uptake of glucose and glucose metabolism in cells; this situation 
leads to a type1 diabetes also known as insulin dependent diabetes mellitus (IDDM). 
An increase in beta cell mass however could be a response to insulin resistance in 
body tissues, whereby insulin may be present but there is a lack of insulin-stimulation 
signaling for a proper cellular uptake of glucose leads to a decrease in glucose 
metabolism: a typical case of type 2 diabetes known as non-insulin dependent 
diabetes mellitus (NIDDM). Environment factors have also been suggested to play a 
significant role in the pathogenesis of diabetes mellitus, but the mechanism is not yet 
clearly defined (Lowe 1998). 
 
Diabetes is a disease of glucose metabolism characterized by a high fasting plasma 
glucose levels. The disease Diabetes Mellitus (DM) was described in 1862 by Ebers 
who found the first description in an Egyptian papyrus in the Tomb of Thebes 
(Turkenburg 1996). Diabetes in Greek means “pipe-like”, illustrating the passage of 
nutrients through the system without being utilized by the body; whereas Mellitus is a 
Latin word for “honey” or “sweet”, as opposed to “Diabetes Insipidus” which is a 
disease caused by a dysfunctional pituitary gland leading to a large volume of sugar 
free urine. Although these distinguishing factors of the two type of diabetes were 
known just less than a century ago (Bach 1994; Tisch and McDevitt 1996), diabetes in 
itself is one of the oldest diseases (3000 - 1500 B.C) which remains amongst the 
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leading causes of death in the world, affecting young (juvenile diabetes), adult 
(maturity diabetes) and old age (late onset diabetes) individuals (Rotter et al. 1990). 
Although the type 1 and type 2 diabetes mellitus have the same phenotype (fasting 
and postprandial hyperglycemia), they account for almost 100% of cases of diabetes 
(10% and 90%, respectively) and, affect about 5% of the population worldwide; but 
both do not share a common etiology (Lowe 1998). Irrespective of the age of the 
affected individuals, the life threatening complications of the disease remain the same. 
In South Africa, the prevalence of diabetes differs within population groups and it 
varies from one geographic area to another. A survey by King et al. (1998) suggested 
that the world prevalence of diabetes in adults will increase by 35%, while the number 
of people with diabetes will increase by 122% from 1995 to 2025. 
 
For these reasons, the future of a potential therapy for Diabetes mellitus (DM) resides 
in the understanding of the morpho-genetics of islet cell neogenesis, which remains 
the ultimate hope for modifications in the treatment of diabetes in general and 
transplantation in particular. In this regard, the first attempt of islet transplantation 
was made in 1893, when sheep pancreatic extracts were transplanted into a young 
human patient who improved for 24 hours only (Williams 1894). A decade later, with 
the discovery of insulin by Banting and Best in 1921, insulin remained the only 
treatment for diabetes until Ballinger and Lacy (1972) successfully treated a diabetic 
rat by transplanting islet isografts. Although many other subsequent transplants 
followed in the 1970s and 1980s in rats (Amamoo et al. 1975; Kemp et al. 1973; Lacy 
et al. 1979) and in humans (Largiader et al. 1980; Najarian et al. 1980; Sutherland et 
al. 1980), there were numerous setbacks related to the use of immunosuppressive 
agents. A breakthrough came in 2000, when Shapiro (2000) reported a 100% success 
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rate with seven human transplants. Despite remarkable progress, the overall world 
success rate toward the treatment of diabetes by islet cells transplantation remains 
very low at 10% (Robertson 2004) due to challenges such as insufficient donor 
organs, the necessity of using immunosuppressive agents (Du Toit et al. 1998a, 
1998b; Muller et al. 1998) and the lack of innovative technical/clinical knowledge 
needed during the transplant process that is acquired from collaboration between 
researchers (Shapiro et al. 2003). It is therefore relevant to explore other avenues of 
self generated cells within the organ itself which could be a way of overcoming the 
challenges of IDDM.  
 
1.1.5.     Pancreatic duct ligation procedure - PDL 
 
The ligation of the pancreatic duct has been an ongoing experimental procedure for 
many years; it was initially aimed at treating a disease, viz. the pancreatitis; however, 
a common opinion emerged then, that ligation of the pancreatic duct induced a 
considerable level of pancreatic atrophy (Auer and Kleiner 1918). This opinion 
corroborated with a work from a prominent researcher of the 19th century Banting, 
who made the same observation while trying to isolate a pancreatic secretion using the 
duct ligation procedure (Bliss 1982). Despite the fact that many authors of that time 
observed atrophy of the pancreas following duct ligation, there was serious 
controversy as to the reason or the origin of a remarkable increase in mass of the 
survived islet (Inada et al. 2008; Solar et al. 2009; Vincent 2007; Wang et al. 1995; 
Xu et al. 2008). 
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Subsequent studies on the pancreas have revealed that transcription factors may be 
involved in the proliferation of the islets after pancreatic duct ligation (Kritzik et al. 
1999; Scoggins et al. 2000; Sharma et al. 1999; Song et al. 1999; Solar et al. 2009; 
Wang et al. 1995). Page et al. (2004) reported a similarity between the formation of 
normal fetal pancreas tissue and the newly-formed beta cells following PDL; this is 
thought to be due to the plausible stem cell capacity of the adult pancreas (Bouwens et 
al. 1998, Githens et al. 1988; Muller et al. 2000). Also,  atrophy of the pancreatic 
cells following duct ligation were noted as a direct consequence to the acinar cell 
death (Abe et al. 1995; Scoggins et al. 2000; Page et al. 2000; Yasuda et al. 1999), 
which triggered islet proliferation and neogenesis from duct-like epithelial cells 
(Bouwens 1998; Githens 1988).  
 
A recent study on the cell lineage in duct ligated pancreas revealed that an increase in 
beta cell mass does not have any contribution from the pre-existing ductal epithelial 
cells. Insulin-producing beta cells develop from pancreatic exocrine duct cells only 
during embryogenesis but not at postnatal life (Solar et al. 2009). These conflicting 
evidences warrant an assessment of other lineage-selective transcription factors for 
endocrine development in PDL tissues. 
 
1.1.6. Transcription factors involved in endocrine development 
 
Transcription factors are involved both in determining early cellular development and 
differentiation of progenitor cells, and later in maintaining the pancreatic cell 
phenotype (Stoffers et al. 1997). Several of these factors have been implicated in 
pancreas development (Kim and McDonald 2002; Sander and German 1997; Servitja 
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and Ferrer 2004) during which they are recognized to be critical regulators of gene 
expression (Jensen 2004; Peshavaria and Stein 1997). These include transcription 
factors of the homeodomain family (Pdx1, Hb9, Pbx1, HNF1β, HNF6, Pax4, Pax6, 
Nkx2.2, Nkx6.1, Isl1, HNF1∝, HNF4∝, and Brn4) (Ahlgren et al. 1996, 1997; 
Gannon et al. 2000; Harrison et al. 1999; Jacquemin et al. 2000; Jonsson et al. 1994; 
Li et al. 1999; Offield et al. 1996; Sosa-Pineda et al. 1997; Solar et al. 2009; St-Onge 
et al. 1997), the basic helix-loop-helix (bHLH) family (Ngn3, Beta2/NeuroD, Hes1, 
p48) (Gradwohl et al. 2000; Ishibashi et al. 1995; Jensen et al. 2000b; Krapp et al. 
1998; Naya et al. 1995, 1997) and the forkhead/winged helix family (Foxa2/HNF3β, 
Foxa1/HNF3∝) (Ang and Rossant 1994; Kaestner et al. 1999; Weinstein et al. 1994). 
 
A number of homeodomain factors, such as Pdx1 (Ahlgren et al. 1996; Jonsson et al. 
1994), Pax4 (Sosa-Pineda et al. 1997), Pax6 (Sander et al. 1997; St-Onge et al. 1997), 
Nkx2.2 (Sussel et al. 1998), Nkx6.1 (Sander et al. 2000), and an additional bHLH 
transcription factor such as NeuroD (Naya et al. 1997) are necessary for 
differentiation and maintenance of mature and differentiated cells. Whilst bHLH 
transcription factor Ngn3 is both necessary and sufficient (Apelqvist et al. 1999; 
Gradwohl et al. 2000) in driving undifferentiated progenitor cells to an endocrine fate; 
Ngn3 expression is ceased before islet cells are fully differentiated (Jensen et al. 
2000a; Schwitzgebel et al. 2000). However, Pdx1 expression in mature differentiated 
cells is specific to insulin-secretin cells (Guz et al. 1995).  
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1.1.6.1. Pancreatic duodenal homeobox gene-1 (Pdx1) 
 
Pancreatic duodenal homeobox gene-1 (Pdx1) is a homeodomain transcription factor 
with a key regulatory function both in pancreas development and the differentiation of 
progenitor cells to become adult beta cells. It is also called insulin promoter factor-1 
(Ipf1) (Ohlsson et al. 1993), islet duodenum homeobox-1 (IDX-1), somatostatin 
transactivating factor-1 (STF-1) (Leonard et al. 1993), or glucose sensitive factor 
(GSF) (Marshak et al. 1996). Pancreatic duodenal homeobox gene-1 belongs to a 
“ParaHox” gene cluster expressed in the lateral endoderm domain at somites 7 to 9 in 
the vertebrate axis that contributes to the development of the pancreas. Pancreatic 
duodenal homeobox gene-1 is a pancreas specific homeoprotein. Because of this, it 
has been found to be a beta and gamma-cell-specific regulatory factor for the 
expression of the insulin and somatostatin genes. Pancreatic duodenal homeobox 
gene-1 also regulates the expression of other islet-specific genes like Glut-2 (Waeber 
et al. 1996), islet amyloid polypeptide (Watada et al. 1996a), and glucokinase 
(Watada et al. 1996b). In the developing pancreas, Pdx1 is first detected at e8.5 in the 
ventral gut endoderm in cells later forming the ventral pancreatic bud. At e9.5 Pdx1 is 
expressed in both ventral and dorsal pancreatic buds (Guz et al. 1995; Offield et al. 
1996). From e11.5 to e13.5, Pdx1 expression is seen throughout developing pancreatic 
epithelium. But at the time when exocrine pancreas begins to form (e14-e15), the 
islets mature into hormone producing-cells and, Pdx1 expression becomes restricted 
to endocrine compartment (e16.5-e18.5), and in dispersed endocrine cells of the 
duodenal wall (Guz et al. 1995; Jonsson et al. 1994; Offield et al. 1996). Later in the 
adult pancreas Pdx1 acts as a master regulator of insulin gene expression (Ohlsson et 
al. 1993; Stoffers et al. 1997b). Subpopulations of somatostatin producing and 
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pancreatic polypeptide producing cells also express Pdx1, but Pdx1 expression is seen 
only in few glucagon-producing cells (Guz et al. 1995; Miller et al. 1994; Ohlsson et 
al. 1993).  
 
Targeted disruption of Pdx1 gene (Jonsson et al. 1994; Offield et al. 1996) and 
homozygous Ipf1 mutations (Stoffers et al. 1997b) result in agenesis of the pancreas. 
Mice with an inactivating mutation in Pdx1 are viable, but pancreatic development is 
arrested at very early stage and animals die within days after birth (Jonsson et al. 
1994). In early pancreas development, a few insulin-expressing cells are detected in 
Pdx1 null mice, suggesting that a population of insulin positive, Pdx1-negative cells 
arise separately from the mature Pdx1 expressing beta cells of the developed pancreas 
(Ahlgren et al. 1996). However, as Stoffers et al (1997a) pointed out “the expression 
of Pdx1 in gut endoderm is essential for the pancreatic program to continue and all 
pancreatic tissues subsequently differentiate from Pdx1-positive precursors” found in 
this germ tissue. Notably, a child homozygous for an inactivating mutation in Pdx1 
will be born without a pancreas (Stoffers et al. 1997a), thereby underscoring the role 
of the Pdx1 transcription factor in the development of the mouse as well as the human 
pancreas (Habener et al. 2005). 
 
The rat, mouse and human Pdx1 genes are localized respectively on chromosomes 12 
(Yokoi et al. 1997), 5 (Sharma et al. 1996) and 13 (Inoue et al. 1996; Stoffel et al. 
1995). The coding region of the Pdx1 gene has two exons, the first encodes for the 
NH2-terminal region of the gene, and the second encodes for the homeodomain and 
COOH-terminal domain (Melloul et al. 2002). The activation of Pdx1 is contained 
within the NH2-terminal region, however its homeodomain is involved in DNA 
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binding; both NH2-terminal region and homeodomain are involved in protein-protein 
interactions (Ashara et al. 1999; Qui et al. 2002). 
 
1.1.6.2.        Neurogenin3 (Ngn3) 
 
Neurogenin3 (Ngn3) is a proendocrine factor belonging to the basic helix-loop-helix 
family bHLH. Neurogenin3 is considered as a marker of islet precursor cells, and has 
been shown to be essential for the development of all endocrine cell lineages of the 
pancreas (Gradwohl et al. 2000; Schwitzgebel, 2001). Pancreatic endocrine cells 
develop from the precursor cells expressing Pdx1 and the bHLH-family transcription 
factor Ngn3. In the mouse, Ngn3 expression is first observed at e9.5, and the number 
of Ngn3 expressing cells increases until e15.5 exactly when islet cell differentiation is 
at its peak and diminishes greatly thereafter with little or no detection of Ngn3 in the 
adult pancreas. Co-expression of Ngn3 with islet hormones (insulin, glucagon, 
somatostatin, pancreatic polypeptide) cannot be detected at this adult stage, although 
all four-islet cell types develop from Ngn3 expressing cells that are found adjacent to 
ductal cells (Gradwohl et al. 2000).  
 
In mice deficient for Ngn3, all islet cell types are absent in every stage of 
development (Gradwohl et al. 2000); but exocrine tissues and ductal tissues develop 
normally. It is evident that expression of Ngn3 is a functional marker of an islet cell 
precursor population in the developing pancreas. Since Ngn3 is both sufficient and 
necessary to initiate differentiation of islet cells during development, it may be 
concluded that the endocrine fate of cells is strictly controlled by the activity of 
specific transcription factors that regulate the cis-acting elements within the promoter 
region of the Ngn3 gene. Hepatocyte nuclear factor 6 (HNF6), HNF3β / FOXA2 and 
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HNF1∝ bind to the Ngn3 promoter, acting as its activators (Lee et al. 2001); while 
Ngn3 on the other hand acts as an upstream regulator for the transcription factors 
Pax6, Pax4, Beta2/NeuroD, Nkx6.1, Nkx2.2 and Isl1 (Gu et al. 2002; Gu et al. 2003, 
Hermans et al. 2002; Smith et al. 2003), and simultaneously represses its own 
promoter (Smith et al. 2004).  
 
Mice homozygous for a null HNF1∝ gene have smaller islets and secrete little insulin 
(Potonglio et al. 1998). Mice embryos missing HNF6 expression present a marked 
reduction in endocrine differentiation, with critically reduced levels of Ngn3 
expression (Jacquemin et al. 2000). A lack of foregut formation will be observed in 
FOXA2 / HNF3β null mice (Ang and Rossant 1994; Weinstein et al. 1994) as well. 
The expression of the HNF factors is therefore considered to be involved in a 
cooperative mechanism in the cell-type-restricted activation of Ngn3 expression, but 
are however not sufficient for Ngn3 expression (Jacquemin et al. 2000).  
 
Neurogenin3 promoter has binding sites for HES1, which is a transcriptional repressor 
of bHLH genes and it is thus believed to inhibit Ngn3 expression through the Notch 
signaling pathway (Jensen et al., 2000b). Overexpression of Ngn3 and an absence of 
HES1 show a similar pancreatic phenotype. Lateral inhibition of Ngn3 expression via 
the Notch-pathway is necessary to allow for the expansion of epithelial cells before 
differentiation. However, premature overexpression of Ngn3 blocks the Notch-
pathway, which leads to a poorly branched ductal epithelium, blockage of exocrine 
development and acceleration in islet cell differentiation. The evidence therefore 
suggests that Notch signalling pathway contributes in regulating the balance between 
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progenitor cell differentiation and proliferation during the pancreas development 
(Apelqvist et al. 1999; Jensen et al. 2000b; Lammert et al. 2001).  
 
1.1.6.3.       Human neurogenic helix-loop-helix protein gene (NeuroD / Beta2) 
 
Human neurogenic helix-loop-helix protein gene (NeuroD / Beta2), which is a bHLH 
factor and an important activator of insulin gene transcription, is also required in order 
to generate a normal mass of pancreatic β- and α-cells. The activation of NeuroD 
expression in cells that co-express Ngn3 and Pdx1 is a very early step in the 
pancreatic endocrine differentiation (Mutoh et al. 1997). NeuroD is activated by 
Ngn3, although these two factors are expressed in different cells. It has been 
demonstrated that NeuroD-positive cells arise from cells that express Ngn3. NeuroD 
expression is detected at e9.5, co-localizing with early glucagon expressing cells 
(Jensen et al. 2000a; Naya et al. 1997).  
 
Null mice for NeuroD gene die 3-5 days after birth due to severe hyperglycemia; the 
islets’ beta cell count is reduced by 75%, numbers of alpha and delta cells are also 
reduced and irregular in shape (Jensen et al. 2000a; Naya et al. 1997). The Notch 
pathway antagonizes NeuroD and bHLH proteins Ngn3. As Jensen and co-workers 
(2000b) reported “Activation of Notch receptors leads to activation of Hairy and 
Enhancer-of-split (HES) -type proteins, which in turn act as transcriptional repressors 
of bHLH genes. Mice lacking Notch ligand Delta like-1 (Dll1) or the DNA-binding 
protein RBP-jk (activator of HES1), have accelerated differentiation of pancreatic 
endocrine cells and subsequently severe pancreatic hypoplasia due to premature 
differentiation of pancreatic stem cells into endocrine cells” (Apelqvist et al. 1999; 
Jensen et al. 2000b; Lammert et al. 2001). 
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1.1.6.4.        Paired box gene 6 (Pax6) 
 
Paired box gene 6 (Pax6) belong to the Pax multigene family of transcription factors 
that contribute to the regulation of pancreatic endocrine cell differentiation (Sussel et 
al. 1998). The paired box gene-6 expression is mainly detected in the eye, the central 
nervous system, the nose and the endocrine pancreas (Turque et al. 1994; Walther and 
Gruss 1991). Sharing similar structure with Pax4 in their corresponding homeodomain 
(Dohrmann et al. 2000; Mansouri et al. 1996), Pax6 is also expressed in both the 
ventral and dorsal developing pancreas; but its expression is detected as early at e9.5 
in the mouse and expressing throughout the pancreas development until the endocrine 
cells are fully formed (Dohrmann et al. 2000; Sander et al. 1997; Sosa-Pineda et al. 
1997; St-Onge et al. 1997).  
 
A mouse lacking Pax6 gene does not survive after birth; the pancreas of the mutant 
contains very few fully differentiated β-, δ- and PP-cells within a malformed islet (St-
Onge et al. 1997). Alpha-cells however are completely absent in this pancreas; but the 
development of the exocrine cells tends to be normal. Mice lacking both Pax4 and 
Pax6 do not develop any endocrine cells; these findings suggest that both Pax4 and 
Pax6 are necessary for the regulation of the final steps in the pancreatic endocrine 
cells differentiation (Dohrmann et al. 2000; Sosa-Pineda et al. 1997; St-Onge et al. 
1997; Sussel et al. 1998).  
 
Advances in research in recent years have shed significant light on how transcription 
factors regulate endocrine pancreas development (Ackermann and Gannon 2007; 
Boucher et al. 2009; Brun and Gauthier 2008; Gasa et al. 2008; Serafimidis et al. 
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2008; Wang et al. 2009; Zertal-Zidani et al. 2007). Although recent evidence has 
shown that newly formed beta cells following PDL do not originate from the pre-
existing ductal epithelium (Solar et al. 2009). The cellular mechanisms involved in 
the recapitulation of these newly formed beta cells remain unknown.  
 
1.1.7. Problem statement 
 
 
The transplantation of whole pancreas has improved the lives of large numbers of 
diabetic patients in the developed world, but the burden of immunosuppressive drugs 
impacts on the quality of life. The transplantation of allogeneic foetal tissue is a 
proven alternative (Muller et al. 1998, 2000, 2001, 2002, du Toit et al. 1998) although 
it is also impacted upon by immune suppressive agents.  The transplantation of adult 
or foetal islets of Langerhans is a promising therapeutic option for the treatment of 
diabetes mellitus (DM), but the low availability of human donor pancreas and the lack 
of suitable donor tissue remain a major obstacle (Shapiro et al. 2000). Duct ligated 
pancreas transplantation has been shown to have the same efficacy as foetal tissue 
(Page et al. 2000, 2004); as the model involved the transplantation of syngeneic 
tissue, immune-suppressive agents were unnecessary. However, the lineage of 
endocrine cell development in the pancreatic duct ligation (PDL) model is poorly 
understood, and is in part one of the questions that this thesis attempts to answer. 
Pancreatic stem cells residing within the ductal epithelium have been used to generate 
islet-like clusters in vitro which has partially reverted DM in animal models (Ramiya 
et al. 2000). Hence, understanding the processes of cellular mechanism in the lineage 
of endocrine cells in the duct ligated induced neogenesis, will be a valuable tool in 
improving beta cell replacement in patients with diabetes, thereby alleviating the 
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burden of Diabetes Mellitus. This present study therefore was initiated to address this 
challenge. 
 
 
1.1.8.     Aim and objectives 
 
 
The aim of this thesis was to establish the morpho-genetic sequence of endocrine cell 
development after a duct ligation procedure, using a range of immunohistofluorescent 
labelling and computerized morphometry techniques.  
The following objectives were defined to achieve this aim: 
1. to describe the morphological changes of the rat pancreas during various 
time periods pre- and post-PDL; 
2. to determine the expression pattern and variations of Insulin, Pdx1, NeuroD, 
Ngn3, Pax6 and caspase3 in the remodelling of the rat pancreas between 
time periods pre- and post-pancreatic duct ligation; 
3. to assess potential correlations between the expression of insulin, Pdx1, 
NeuroD, Pax6 and caspase3; 
4. to investigate the time-related profile and efficiency of co-expression of 
Pdx1, NeuroD, Ngn3, Pax6 and caspase3 with insulin. 
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Chapter 2.  Materials and Methods 
 
2.1.  Ethical issues 
 
Ethics approval was obtained from the University of Stellenbosch Ethics Committee 
reference number P04/01/001. This study complies with the recommendations of the 
Declaration and the guiding principles laid down by Animal Welfare Organization 
and the Society for the Prevention of Cruelty to Animals (SPCA). 
 
2.2.  Laboratory animals 
 
The difference in the anatomy, physiology, cell and molecular biology of the pancreas 
in humans and rodents as described in the literature have very little implication to this 
study, because of the similarities in the morphological events that take place when the 
pancreas of both the human and rodent undergo duct ligation. Rats (Rattus 
norvegicus) were used in preference to mice (Mus musculus) because of the advantage 
of being larger in size which gives easy access to the organ under study. Also, these 
animals are readily available as inbred lines. 
  
Seventy-eight male, randomly selected healthy Sprague Dawley rats were obtained 
from the Central Animal Unit of the Faculty of Health Sciences, University of 
Stellenbosch. The rats were weighed and put into thirteen (13) groups of six animals 
each, corresponding to the time periods post-PDL of 6, 12, 24, 36, 48, 60, 72, 84, 96, 
108 and 120 hours, and  time periods pre-PDL of 0 and 5 hours at which animals were 
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killed. While animals in both groups pre-PDL 0 hour and 5 hours did not undergo 
duct ligation, animals in group pre-PDL 5 hours had the abdomen opened and closed 
only (sham operation) (Table 1). 
  
Table 1.  Animals in groups of various time periods pre- and post-PDL showing the 
number of animals killed 
 
Procedures                 Groups 
        time periods 
                  (hr) 
            Total 
        animals
             (n) 
   
Pre-PDL 
           
 
Post-PDL 
 
 
 
 
 
 
 
 
 
 
 
 
           
                    0          
                    5 
 
                     6         
                   12 
                   24 
                   36 
                   48 
                   60 
                   72 
                   84 
                   96 
                  108 
                  120 
 
 
              6 
              6    
              
              6 
              6 
              6 
              6 
              6 
              6 
              6 
              6 
              6 
             6 
              6 
            78 
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2.3.  Pancreatic duct ligation  
 
A fully equipped microsurgery laboratory at the Department of Anatomy and 
Histology was used for the PDL surgical procedure. One night prior to PDL, rats were 
housed in clean cages and in a thermally controlled environment with free access to 
water but no food. 
 
On the day of the surgical procedure, induction of anaesthesia was achieved by 5% 
halothane vaporized in O2 such that there was no spontaneous movement and no 
withdrawal responses to tail or foot pinch. Abdominal hair was shaved using a 
surgical blade, one centimetre on either side of the linea alba to avoid excessive heat 
loss. Great care was taken not to abrade or cut the skin. The shaved portion of the 
abdominal surface was then cleaned with betadine antiseptic solution containing 
providone-iodine at 10 mg/ml (Adcock Ingram Pharmaceuticals, Industria, 
Johannesburg, RSA).  
 
The animals were placed on their back (dorsal recumbency); the hind limbs were 
maintained on the surgical table by means of a paper tape with a minimum tension to 
avoid muscle strains. A mid-line laparotomy incision starting from the tip of the 
xiphoid process to about one centimetre above the pelvic symphysis was made to 
obtain access to the abdominal cavity. The stomach and the duodenum were drawn 
out and reflected cranially to expose the pancreas. The topographical position of the 
pancreas was noted, and cotton buds were used to prise the pancreas away from the 
surrounding tissue. A Zeiss OPMI-1 operating microscope equipped with a zoom and 
a focus adjustment (Carl Zeiss, AG, Oberkochen, Germany) aided in identifying the 
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colourless pancreatic duct. The pancreatic duct was traced distally towards the splenic 
lobe of the pancreas. At about  1/3 proximal to the tail end of the pancreas (splenic 
lobe), a tight single suture occluding the duct was made using a resorbable suture 
material (5/0 sterile white braided silicone treated polyester, USP, Davis and Geck, 
Isando, South Africa) soaked in saline solution (Figure 3). Care was taken to avoid 
damage to the underlying blood vessels.  
 
 
Figure 3. The pancreas of the laboratory rat is prised away to expose the point of 
ligation (double bold line) in the splenic lobe. 
 
After ligation, 5ml of warm saline solution was introduced into the abdominal cavity 
to prevent post-PDL dehydration. The laparotomy incision was closed in two separate 
layers of a continuous (blanket) stitching using 5/0 sterile white braided silicone 
treated polyester (Davis and Geck, Isando, South Africa); first the peritoneum 
together with the abdominal muscles were sutured and the skin followed thereafter, 
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the whole procedure taking approximately 10 minutes. A subcutaneous injection of 
2.5mg of Amoxil (Smith-Kline Beecham Pharmaceuticals, Midrand, RSA) and 0.5mg 
streptomycin (Novo-Strep 5g/15 ml, Novo Nordish (Pty) Ltd, Johannesburg, RSA) 
was administered as a single subcutaneous dose at the scruff of the neck to guard 
against infection; the wound was then swabbed with an antiseptic rub (Beige 
Pharmaceuticals Pty. Ltd., Edenvale, South Africa) to minimize scratching. Animals 
were returned to clean laboratory rodent cages under a 60 watt lamp necessary for 
rapid recovery and to counter hypothermia, and were housed in a thermally controlled 
environment with free access to water and standard rat chow (Epol, Midrand, RSA) 
until they were killed. The effects of the post procedural treatment regimens, which 
might impact on the recapitulation process of endocrine cells development were not 
considered and remain an unknown parameter in this study. 
 
2.4.  Histological study of the PDL Tissue  
2.4.1. Removal and processing 
 
On the day of tissue collection corresponding to time periods pre- and post-PDL, 
animals were anaesthetised as described earlier; placed in a dorsal recumbence, the 
hind limbs were maintained on the surgical table by means of a paper tape, and a mid-
line laparotomy incision was made along the previous incision to gain access to the 
abdominal cavity. The stomach and the duodenum were drawn out and reflected 
cranially to expose the pancreas. A portion from the 1/3 proximal to the tail end of the 
pancreas was surgically isolated and removed after the surrounding blood vessels had 
been ligated. The animals were then euthanized by introducing 200mg/kg sodium 
pentobarbitone into the abdominal cavity and the carcases disposed of by incineration.  
http://scholar.sun.ac.za
36 
 
The isolated portions of the pancreas were excised (5x5mm) (PDL tissues) and placed 
in labelled tubes containing Bouin’s fluids (Appendix 1) for tissue preservation.  
Approximately 6-18 hours later, PDL fixed-tissues of the pancreas were placed in 
labelled plastic cassettes and were processed through standard histology routine 
(Appendix 2). The PDL tissues were then embedded in paraffin wax (at 55ºC) and the 
resulting tissue blocks were kept at room temperature (20-25ºC) until sectioning took 
place. 
 
2.4.2.      Sectioning and H&E staining  
 
Sectioning and staining procedures took place at the Walter Sisulu University, within 
the facility of the Department of Anatomy, Histology and Embryology, with the 
approval of the Faculty of Health Ethics and Biosafety research committee reference 
number 0016-04. 
 
2.4.2.1. Sectioning 
 
One night prior to sectioning, PDL tissue blocks were placed on the cold plate; 12 
serial sections at 5µm thick were obtained from each block using a motorized rotary 
microtome equipped with a section transfer system-STS (Microm International HM 
355S). The water bath of the STS was filled with de-ionised water and was 
replenished between blocks of different groups to avoid contamination. Tissue 
sections were then mounted from warm de-ionised water (at 40ºC) onto frosted 
microscope slides.  
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Slides were labelled as follows: the groups representing time periods pre- and post-
PDL were prefixed 1 to 13. Each one of the 6 animals in each group were identified 
by the radicals A, B, C, D, E and F; the 12 serial sections representing the staining 
procedures used in the study were attributed the suffixes 1 to 12. Therefore, a slide 
labelled for instance 3A8 means the 8th serial section (or double staining procedure, 
insulin and caspase3) from tissue block A (1st animal) in group 3 (6 hours-time post-
PDL) (Appendix 3).  
 
A total number of 936 tissues slides were labelled, and sections were allowed to air 
dry overnight at room temperature (20-25ºC) to favour firm adhesion to the glass 
slides in order to prevent tissue loss during subsequent incubations and washes. 
Labelled slides (n=78) bearing the same suffixes (serial section number) were put in 
the same slide box. Twelve labelled microscope slide boxes in total were constituted, 
and the boxes were labelled according to the staining procedure to which the sections 
were exposed.  
 
2.4.2.2. H&E staining  
 
Haematoxylin and eosin (H&E) staining procedure (Appendix 4) was applied to 
sections in slide box 12 containing the 12th serial sections obtained from all groups 
involved in the study. The stained slides were viewed under the light microscope 
mainly to validate the morphological changes that occurred in the PDL tissues of the 
pancreas in various periods of time after PDL.  
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2.5.     Immunohistochemical study of the PDL tissue 
2.5.1.     Immunofluorescence procedure and deparaffinization 
 
Two immunofluorescent staining procedures were used in the study. The simple-label 
immunofluorescent (SIF) staining was used to determine the expression of individual 
primary antibodies, while double-label immunoflurescent (DIF) staining was used to 
investigate the relationship between two antigens in the same tissues 
imunofluorescent staining procedures.  
 
The method controls for the immunofluorescent staining of PDL tissues were not 
considered in this study. It is inappropriate for a chronobiology study and would have 
been very expensive to use a control for each period of times. 
 
A plastic rack carrying tissue slides were placed into an autostainer machine with a 
built-in oven at 65°C. Slides were kept in an oven overnight to clear water from 
sections and were allowed to cool down for 30 minutes prior to treatment. Sections 
were deparaffinised and rehydrated (Appendix 5); sections were not allowed to dry 
until the in-situ antigenic determinants were exposed.  
 
2.5.2.2. Detection system 
 
The antigen retrieval techniques and fluorescence labeling were used as the detection 
system for immunoflorescent staining. 
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2.5.2.2.1. Antigen retrieval 
 
To retrieve the antigens in tissues, an electric autoclave at 1000 watt was used. Plastic 
racks carrying deparaffinised tissue sections were immersed into the autoclave 
container filled with 100ml pre-treatment solution of 10mM citrate buffer (pH 6.0); 
the autoclave was switched on until temperate reached 100°C in about 5 minutes. 
Slides were maintained in boiling pre-treatment solution for further 15 minutes, when 
the container was taken off the autoclave and slides were allowed to cool in the pre- 
 treatment solution for 20 minutes at room temperature before immunostaining took 
place. 
 
2.5.2.2.2. Immunochemical markers 
 
The choice for the markers to label the homeodomain proteins (Pdx1, Ngn3, NeuroD 
and Pax6) involved in endocrine pancreas development was based on the hierarchy in 
the time related expressions of the transcription factors (Figure 4), and the availability 
of these markers on the market by the time the study was initiated.  
 
The markers used as primary antibodies were the markers for endocrine pancreas 
development genes and cellular apoptosis (Caspase-3) both polyclonal and raised in 
rabbit, and the monoclonal marker for Beta cells (insulin) raised in mouse (Table 2).  
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Figure 4. A single step in endocrine differentiation in the mouse pancreas showing 
the stage-related timing of expressions of some transcription factors (Modified from 
Schwitzgebel et al. 2000). 
 
Table 2. Primary antibodies and dilutions used in the study 
 
Antibody Clone N0. Raised in Formata Dilution Sourcesb 
Insulin Lv1384150 Mouse AF 1:50 Chemicon 
Pdx1 0607035666 Rabbit PurI 1:200 Chemicon 
Ngn3 Ab5684 Rabbit PurI 1:200 Chemicon 
NeuroD1 Ab15580 Rabbit PurI 1:25 Chemicon 
Pax6 Lv1375908 Rabbit PurI 1:500 Chemicon 
Caspase3  Lv2359461 Rabbit PurI 1:10 Chemicon 
aPurI, Purified Immunoglobulin; AF, Ascite Fluid. 
bChemicon International Inc., Belerica, USA. 
 
 
However, Dichloro Triazinyl Amino Fluorescein (FITC) and Cyanine-3 (Cy3) were 
used as secondary antibodies; both have a dual-label fluorescent incorporated 
compound and were goat anti-Rabbit IgG and goat anti-mouse IgG respectively 
(Table 3). 
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Table 3. Secondary antibodies and dilutions used in the study 
 
Antibody Label Form Format Dilution Sourcec 
FITC/DTAF Fluor Dual Lyophilized 1:50 Chemicon 
Cy3 Fluor Dual Lyophilized 1:200 Chemicon 
cChemicon International Inc., Bellerica, USA. 
 
 
The markers (primary antibodies and secondary antibodies) were purchased from 
CHEMICON International Inc, (Bellerica, USA). 
 
A fluorescent nuclear dye 4',6-diamidino-2-phenylindole (DAPI) with an antifade 
solution was used as counterstain to labelled  cell nuclei. Microscope glass coverslips 
(Chance Proper Ltd, Smethwich, Warley; England) were used as coverslips to all 
sections and, a mixture of Distyrene, a plasticizer and xylene (DPX) was used to fix 
the edges of the coverslips in place. 
 
2.5.3.      Immunofluorescent labeling 
 
Sections were rinsed in 500mL de-ionized water for 5 minutes and immediately 
placed in oxidation blocking solution (PBS + 2% (v/v) hydrogen peroxidise) once for 
5 minutes; this helped quench the endogenous peroxidase by blocking the non-
specific antigen sites found in tissues. A diamond pen was used to draw a circle 
around the sections to help maintain fluid during subsequent incubations. Sections 
were rinsed in PBS and were stained immediately.  
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2.5.3.1. Simple-label immunofluorescence  
 
The immunostaining protocol was identical across individual antibodies as modified 
and adapted from their individual data sheets and was applied as follows: The sections 
were immersed for 3 minutes in working buffer1 (PBS + 2% v/v normal goat serum). 
Excess buffer was tapped off from slides, caution was taken not to touch sections or 
allow them to dry. The primary antibodies were quickly applied on sections using 
their respective working dilutions as shown in Table 2 above, and the sections were 
incubated with 10µl of the primary antibodies for 30 minutes at room temperature. 
The sections were next rinsed for 3 minutes in working buffer1; excess buffer was 
tapped off the slides and subsequently incubated with 10µl of FITC for 30 minutes at 
room temperature. After a wash for 3 minutes with 0.05% Tween20 in PBS, the 
sections were finally rinsed in distilled water for 3 minutes; sections were 
counterstained and coverslipped.  
 
2.5.3.1.1. Double-label immunofluorescence with PIFD approach in a one-step 
incubation 
 
A parallel approach of immunofluorescence dual labeling (PIFD), was preferably 
applied to study the relationship between the expression of anti-Pdx1, anti-Ngn3, anti-
NeuroD, anti-Pax6 and anti-Caspase-3 with that of anti-insulin; because their primary 
antibodies and that of insulin are derived from different species, rabbit and mouse 
respectively.  
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Sections were immersed in a working buffer1 for 3 minutes and sections were 
incubated for 30 minutes with 10µl of a mixture of the two primary antibodies (raised 
from different species, mouse and rabbit) solution at appropriate respective working 
dilutions. Sections were rinsed in working buffer1 for 3 minutes and subsequently 
incubated with 10µl in a mixture of two secondary antibodies FITC and Cy3 at 
appropriate dilution as shown in Table 3 above for 30 minutes. Sections were washed 
in 0.05% Tween20 in PBS for 3 minutes and were finally rinsed in distilled water for 
3 minutes; sections were counterstained and cover slipped as described earlier. After 
staining was completed, slides were stored in the dark at 4°C until viewed.  
 
2.6.      Computer-Assisted Quantitative Image Analysis (CAQIA) 
2.6.1.       Slide viewing and image capturing 
 
After immunofluorescent staining, labelled tissue slides (n=858) were grouped 
according to their prefixes following the time periods pre- and post-PDL, and were 
put (n=78) in their respective slide boxes. Slide boxes were viewed under a Zeiss 
Axio imager A1 microscope (series number 3517001133) equipped with a 
Fluorescent HBO 100 (Carl Zeiss Vision GmbH, Zepplinstrasse 4, 85399 München-
Hallbergmoor, Germany) and a Carl Zeiss black and white camera. The system is 
computerized and driven by MECER premium Pentium 4 HT hardware systems 
which are operated by Windows XP 2007.  
 
To minimized photo bleaching during image acquisition, tissue slides were subjected 
to blue light for less than 10s; exposure time for image capture was always less than 
1s. Immunofluorescent images were captured at 20x magnification using an A-Plan 
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lens [numerical aperture (NA), 0.25; Zeiss], and the general morphological aspect of 
the immunofluorescence images of the pancreas was evaluated to determine if the 
immunofluorescent procedure had any impact on the morphology of tissue samples; 
the captured images were then exposed to quantitative image analysis. 
 
2.6.2. Quantification of protein expression in PDL pancreas 
 
The protein expression profiles in tissues were determined by the fluorescence 
emissions obtained from positive labelled cells; the resulting images were acquired by 
the Zeiss colour camera with the same exposure time and processed identically under 
a multidimensional image acquisition module of Axiovision 4.8 (Imaging System, 
Carl Zeiss; München, Germany) driven by a computerized system. The FITC-labelled 
cells were excited at 490 nm and emitted green (at 520 nm), while Cy3-labelled cells 
were excited at 456 nm and emitted red (562 nm); all counterstained DAPI-labelled 
nuclei were excited at 365 nm and emitted blue (463 nm). The captured images 
accurately represent the visual impression of the observer. 
 
The digital images were segmented and the features of the positive labelled cells were 
programmed using the automeasurment software of Axiovision 4.8 and MTB2004 
configuration (both Carl Zeiss Vision GmbH). All the images to analyse were given a 
name (image name) and the features of measurements were set as Regions and Field 
features as described below: 
• The Regions consisted of each labelled cell (Count) and the area of the 
individual labelled cell (Area) 
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• The Field feature consisted of the total number of labelled cells (Total count) 
expressed n, the total area of labelled cell (Total Sum) expressed in µm2 and 
the expression index. 
 
The number of fluorescent labelled cells for the same antigen were counted and their 
cell surface areas measured by automation. Data were recorded per time pre- and 
post-PDL for each immunofluorescence procedure and saved automatically in files 
(Appendix 6).  
 
2.7. Definitions  
 
The landmarks in targeting the expression profile of homeodomain proteins involved 
in the remodelling of the pancreas after surgical duct ligation were determined by the 
morphological changes observed under H&E slides of the PDL tissues of the pancreas 
during various time periods post-pancreatic ligation (PDL). These landmarks were 
used in the analysis of expression patterns of transcription factors following the 
quantification of protein expression at each period of time pre- and post-PDL. The 
resulted expression of individual homoedomain protein across the time periods pre- 
and post-PDL and their co-expression with insulin, defined the lineage of endocrine 
cell development in the duct ligation pancreas in the laboratory rat. 
 
The expression index, which is essential in quantifying the protein expression in all 
the tissue sections in each group, was calculated using the following formula: 
Expression index = total number of count / total area 
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Dual gene expression (Co-expression) of different homeodomain proteins with insulin 
was expressed as a ratio of the expression index of insulin per the expression index of 
each one of the proteins across the time periods pre- and post-PDL. Co-expression of 
insulin and other homeodomain proteins was defined by a curve parallel to the curve 
of insulin expression index across the time periods pre- and post-PDL.  
 
The efficiency of co-expression was arbitrarily defined by the value of mean ratio 
(score without unit) of insulin expression divided by each expression of the other 
homeodomain proteins, occurring within the time interval of 12 hours cycle. Levels of 
ratio of co-expression were said to be optimal or high (>25), average or medium (20-
25), and weak or low (20). 
 
2.8. Statistical analysis and Immunohistofluorescence evaluation  
 
Continuous variables were expressed as mean ± Standard Deviation (SD) or Standard 
Error of Mean (SEM). To analyse individual homeodomain protein expression and the 
efficiency of co-expression of proteins, analysis of variances (one-way ANOVA) was 
used to compare the means of protein expression indices across the different time 
periods pre- and post-PDL. Simple coefficient of correlation “r” was calculated to 
assess potential associations between the different protein expression indices in the 
study. P-values less than 0.05 were considered statistically significant; no post hoc 
test was done. Data were exported from MS Excel (Microsoft Inc, USA) to the 
Statistical Package for Social Sciences (SPSS) version 15 for Window (SPSS Inc, 
Chicago, IL, USA) for statistical analysis. 
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Chapter 3. Results 
 
3.1. Histological assessment of post-PDL tissues 
 
The microscopic studies of the post-PDL tisues showed some morphological changes 
across the time periods post-PDL. Photomicrographs were grouped in a chronological 
order and the changes observed were similar between certain time periods and led to 
the time periods post-PDL being grouped together and were considered landmarks as 
follows: Landmark I: 6, 12 and 24 hour; Landmark II: 36, 48 and 60 hours; Landmark 
III: 72 hours; Landmark IV: 84, 96, 108 and 120 hours (Figure 5).  
 
The islets of Langerhans appeared unaffected in the first 24 hours post-PDL; but there 
was evidence of generalised granulation of acinar cells having various shapes from 6 
hours through to 24 hours post-PDL. A progressive separation between the acinar 
cells and their basement membrane was observed at 12 hours. A complete 
fragmentation of acinar cells was seen at 24 hours. Some fibroblastic cells were seen 
undergoing mitosis in the underlying connective tissue through this first landmark 
(Figure 5I).  
 
Between 36 and 60 hours, there was a distinct crescent-like clumping appearance of 
the acinar cells that became progressively atrophied and shapeless. However, there 
was infiltration of macrophages in the pancreatic tissue (Figure 5II). 
 
 Abundant levels of acinar deletion occurred at higher rate at 72 hours post-PDL, with 
evidence of acinar cell necrosis. The islet cells were detached from the underlying 
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connective tissues with a considerable amount of binucleated macrophages observed 
within them; there were few visible surrounding necrotic cells (Figure 5III).  
 
At 84 hours, some necrotic acinar cells were still visible; concurrently there was an 
ongoing acinar cell replacement. However, the islet cells remained unaffected up to 
this hour. There were some ductal epithelial cells that have begun to bud off and this 
continued over the following 96 to 120 hours. A glandular formation was apparent at 
96 hours with numerous infiltrated mononuclear macrophages. There was evidence of 
cellular regeneration through to 120 hours with the presence of clearly observable 
ducts, fully formed acini and islet cells. The diameter of the ducts was clearly 
delineated with somewhat low cuboidal acinar cells, the presumptive centroacinar 
ducts. There was evidence of glandular secretion. A rich supply of capillary networks 
was seen in the vicinity of islets of Langerhans. Many intercalated ducts showed out 
pocketing of their lumens at 120 hours contributing to the endocrine cell formation 
(Figure 5IV).  
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Figure 5. Photomicrographs of morphological changes at various landmarks for time 
periods post-PDL. 
 A) x200, bar: 10µm; B) x400, bar:5µm. 
Arrow: granulated cells; Arrow head: basement membrane; dash line: fibroblastic 
cells. Letter C: clump of acinar cells; Brocken arrow: infiltrated macrophages; Star: 
acinar deletion; BV: blood vessel; D: duct; e: duct evagination. 
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3.2.  Morpho-immunofluorescent evaluation of PDL tissues 
 
Figure 6 illustrates the fluorescent reflection of the time-related expression of Pdx1 
across the time periods pre- and post-PDL.  The fluorescent images were used to 
analyse the protein expression of single homeodomain protein as well as the dual 
expression of individual homeodomain proteins with insulin. 
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Figure 6.  Expression of Pdx1 at time periods pre-and post-PDL (x200). 
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Following the landmarks as determined by the morphological changes observed in 
H&E micrographs, the immunofluerescent studies revealed high expression of some 
proteins within a specific landmark as represented in Figure 7. 
 
In the first landmark interval of 6-24H, the expression of Caspase3 was prominent at 6 
H, and similarly for Pdx1 expression. Ngn3 expression was noted at 36 hours for the 
second landmark of 36-60H. For the fourth landmark of 84-120H, however, Pax6 
expression as well as insulin expression was observed at 84H and NeuroD expression 
was seen at 120H. There was no protein expression in the third landmark of 72H. 
 
 
 
Figure 7. Immunofluorescent of the PDL pancreas showing the highest expression of 
different homeodomain proteins at various time post-PDL  (x200). 
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3.3. Immunohistofluorescent analysis of protein expression  
3.3.1. Single expression of protein in PDL tissues 
3.3.1.1. Expression of Caspase-3 
 
The caspase3 expression was defined by three modes at 6 hours, 24 hours and 72 
hours. The highest expression was observed at 6 hours, with higher variability of the 
expression at both the 1st and the 2nd mode. The nadir of the curve was observed at 
108 hours (Figure 8), lower than that observed at 0 and 5 hours pre-PDL. Caspase3 
expression varied significantly across the period of times pre- and post-PDL 
(ANOVA; P=0.013). However, the expression of caspase3 had a significant and 
positive correlation with that of Ngn3 (section 3.2.1.4; r=0.285; P=0.011). 
 
 
 
 
Figure 8. Caspase3 expression across the period of times pre- and post-PDL. 
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3.3.1.2. Expression of Insulin 
 
Insulin expression varied significantly (ANOVA; P0.0001) across the different 
periods of time pre- and post-PDL. The highest mean of the expression index was 
observed at 84 hours, while the lowest index was observed at 120 hours post-PDL. 
The latter expression was higher than the mean expression index at the time periods 0 
and 5 hours pre-PDL (Figure 9). However, the expression of insulin had a significant 
and positive correlation with both Ngn3 (r=0.245; P=0.031) and Pax6 (r=0.301; 
P=0.007). 
 
 
 
Figure 9. Insulin expression across the period of times pre- and post-PDL. 
 
 
3.3.1.3. Expression of Pdx1  
 
The mean expression index of Pdx1 was unequally distributed, but without significant 
difference (ANOVA; P=0.177) between the various time periods of the experiment 
(Figure 10). The highest expression index was concurrent with 6 hours post-PDL, 
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while the lowest mean of the expression index was at 108 hours post-PDL and were 
similar to those of time periods pre-PDL 0 and 5 hours, respectively. However, there 
was high variability of Pdx1 expression between 6 hours and 24 hours. Furthermore, 
there was no correlation with any of the proteins expression in the study: r=-0.025 and 
P=0.831 with Caspase3, r=0.116 and P=0.311 with Insulin, r=-0.076 and P=0.510 
with Ngn3, r=-0.031 and P=0.785 with NeuroD and r=0.114and P=0.322 with Pax6. 
 
 
 
Figure 10. Pdx1 expression across the period of times pre- and post-PDL. 
 
 
 
 
3.2.1.4. Expression of Ngn3  
 
The Figure 11 depicts the curve of Ngn3 expression with anabase part between 0 and 
36 hours and catabase part between 48 and 120 hours. There was a significant 
difference (ANOVA; P0.0001) between the mean expression indexes across the 
different periods of time pre- and post-PDL. The peak of the curve was observed at 36 
hours, while the nadir of the curve was at 108 hours post-PDL. Furthermore, there 
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was a significant and positive correlation between the mean index of the Ngn3 
(r=0.245; P=0.031) expression and insulin and between Ngn3 (r=0.285; P=0.011) and 
Caspase3 expression. 
 
 
Figure 11.  Ngn3 expression across the period of  times pre- and post-PDL. 
 
 
3.3.1.5. Expression of NeuroD 
 
The variations of the NeuroD expression across the different periods of time pre- and 
post-PDL are shown in Figure 12. The highest (spike) of the NeuroD expression was 
observed at 108 hours and presented with a higher variability as compared to the rest 
of the time periods which had a more intermediate mean index between them. The 
lowest mean of expression indexes was at 48 hours post PDL. However, there was no 
significant difference (ANOVA; P=0.588) between the mean indexes across the time 
periods in the study. There was also no correlation between NeuroD expression and 
other protein expression in the study: r=0.007 and P=0.955 with caspase3, r=-0.062 
and P=0.442 with insulin, r=-0.031 and P=0.785 with Pdx1, r=-0.056 and P=0.623 
with Ngn3 and, r=-0.058 and P=0.614 with Pax6. 
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Figure 12.  NeuroD expression across the period of times pre- and post-PDL. 
 
 
3.3.1.6. Expression of Pax6 
 
The curve of the mean expression index of Pax6 expression was defined by three 
modes, observed at 12 hours, 84 hours and 108 hours (Figure 13). There was a 
significant difference (ANOVA; P0.0001) of protein expression between all the 
time periods pre- and post-PDL, with the highest mean index at 84 hours. The lowest 
mean index was at the time periods pre-PDL 0 and 5 hours. The highest variability of 
Pax6 expression was observed at 108 hours, while significant and positive correlation 
was seen between Pax6 (r=0.301; P=0.007) and insulin expressions. 
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Figure 13. Pax6 expression across the period of times pre- and post-PDL. 
 
 
 
3.3.2. Dual expression of proteins in PDL 
3.3.2.1. Co-expression of insulin with Caspase3 
  
Figure 14 shows the mean expression index of insulin and that of the co-expression 
(insulin-caspase3) as covariate. The highest mean expression index of the co-
expression occurred between 6 and 24 hours post-PDL, whereas the highest 
expression index of insulin occurred later at 108 hours post-PDL. Co-expression 
index was low at time periods pre-PDL 0 and 5 hours as well as at time periods post-
PDL 36, 60, 84 and 120 hours. 
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Figure 14. Dual expression index across the period of times pre- and post-PDL. 
Insulin expression (blue); Co-expression (green) 
 
The efficiency curve in Figure 15 represents the co-expression index of insulin and 
caspase3. It shows four modes at 6 hours, 24 hours, 72 hours and 108 hours post-
PDL. There was a statistically significant difference (ANOVA; P0.0001) of mean 
values between all the time periods pre- and post-PDL. The highest mean level of 
efficiency was at 24 hours post-PDL; however, the variability of efficiency was very 
high at that same time. The time periods pre-PDL 0 and 5 hours had the lowest 
efficiency mean value. 
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Figure 15. Efficiency levels of Caspase3/Insulin co-expression across the period of 
times pre- and post-PDL. 
 
3.3.2.2. Co-expression of Insulin with Pdx1 
 
The highest mean expression index of insulin was observed at 36 hours post-PDL, 
while the highest peaks of the co-expression index of insulin and Pdx1 were 
successively observed at 24 hours and 108 hours post-PDL (Figure 16). The mean co-
expression was low at time periods 0 and 5 hours similar to that observed at 72 and 96 
hours post-PDL. 
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Figure 16. Dual expression index across the period of times pre- and post-PDL. 
Insulin (blue); Co-expression (green). 
 
The efficiency level of co-expression of insulin and Pdx1 was characterized by a uni-
modal curve with a peak at 36 hours (Figure 17). This peak was defined by higher 
variability. There was a significant difference (ANOVA; P0.0001) between all the 
times periods pre- and post-PDL. However, the time periods pre-PDL 0 and 5 hours 
had the lowest levels of efficiency. 
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Figure 17. Efficiency levels of Pdx1/Insulin co-expression across the period of times 
pre- and post-PDL. 
 
3.3.2.3. Co-expression of Insulin with Ngn3 
 
The highest mean levels of expression index of insulin occurred between 72 hours and 
84 hours post-PDL, whereas the highest peaks of co-expression of insulin and Ngn3 
were successively observed at 12 hours and 120 hours post-PDL. The co-expression 
index at time periods pre-PDL 0 and 5 hours was higher than most of the time periods 
post-PDL (Figure 18).  
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Figure 18. Dual expression index across the period of times pre- and post-PDL. 
Insulin (blue); Co-expression (green). 
 
Figure 19 depicts the mean efficiency levels of Insulin and Ngn3 co-expression. The 
highest level of efficiency was concurrent at 12 hours. A significant difference 
(ANOVA; P0.0001) was observed between the time periods pre- and post-PDL. 
Low efficiency levels observed at time periods 0 and 5 hours was similar to that 
observed at time periods 48 and 108 hours post-PDL.  
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Figure 19. Efficiency levels of Ngn3/Insulin co-expression across the period of times 
pre- and post-PDL. 
 
3.3.2.4. Co-expression of Insulin with NeuroD 
 
The curve of co-expression index of insulin and NeuroD was dominant in comparison 
with that of Insulin expression at the time periods 0 and 5 hours pre-PDL, 6 hours and 
later between 60 and 84 hours post-PDL with an overshoot observed at 72 hours. This 
contrasted with the plateau mode of insulin expression between 60 hours and 84 hours 
post-PDL. The co-expression and insulin expression were similarly low between 6 
and 24 hours post-PDL (Figure 20). 
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Figure 20. Dual expression index across the period of times pre- and post-PDL. 
Insulin (blue); Co-expression (green). 
 
However, the mean efficiency levels of insulin and NeuroD co-expression reached a 
highest peak at 12 hours (Figure 21). A higher variability of efficiency was observed 
at 6-24 hours. There was a significant difference (ANOVA; P=0.007) of efficiency 
mean values between the time periods pre- and post-PDL, with the lowest mean value 
observed at 0 and 5 hours pre-PDL and 96 hours post-PDL 
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Figure 21. Efficiency levels of NeuroD/Insulin across the period of times pre- and 
post-PDL. Insulin (blue); Co-expression (green). 
 
3.3.2.5. Co-expression of Insulin with Pax6 
 
The highest mean of the co-expression index of insulin and Pax6 was observed at 12 
hours post-PDL, whereas the expression of insulin was totally dominant over that of 
the co-expression at time periods pre-PDL 0 and 5 hours, with a plateau mode 
between 36 hours and 84 hours (Figure 22).  
http://scholar.sun.ac.za
69 
 
 
 
Figure 22. Dual expression index across the period of times pre- and post-PDL. 
Insulin (blue); Co-expression (green). 
 
The mean efficiency levels of insulin and Pax6 co-expression reached a highest peak 
at 24 hours (Figure 23). There was a significant difference (ANOVA; P0.0001) of 
mean values between the time periods pre- and post-PDL. The levels of efficiency at 
time periods pre-PDL were higher than that observed at 108 hours post-PDL. 
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Figure 23. Efficiency levels of Pax6/Insulin co-expression across the period of times 
pre- and post-PDL 
 
3.3.3.  Comparison of efficiency levels in protein co-expression 
 
Table 4 compares the levels of efficiency for the various proteins co-expressions with 
insulin. There was a significant difference of efficiency levels across the genes 
transcription factors involved in the study (ANOVA; P0.05). 
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Table 4.  Different levels of efficiency of protein co-expressed with insulin  
Co-expressed 
proteins 
Means ±SD  
of ratio      
Times concurrent   
with higher ratio    
Ins/Casp3 15±2.5 24 hours 
Ins/Pdx1 24±11.9 12 hours 
Ins/Ngn3 27±18.8 12 hours 
Ins/NeuroD 20±26.5 12 hours 
Ins/Pax6 20±16.7 24 hours 
 
The optimal or high efficiency of co-expression was observed for insulin and Ngn3 
co-expression, while an average or medium efficiency was for the co-expression of 
insulin with Pdx1, insulin with NeuroD and insulin with Pax6. Weak or low 
efficiency was observed for Insulin and caspase3 co-expression. 
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Chapter 4. Discussion and Conclusion 
 
The present study demonstrated that there is a clear and significant relationship 
between morphological changes and protein synthesis in the remodelling of endocrine 
development in duct ligated pancreas. Furthermore, the expression of endocrine 
developmental transcription factors with regard to the insulin expression revealed that 
islet transplantation for an optimal result should occur earlier than the morphological 
manifestation of new beta cell formation. These findings are critical in islet 
transplantation, an important tool for the treatment of diabetes mellitus. 
 
4.1. Relationship between morphology and protein expression in PDL 
pancreas 
 
The results obtained from the morphological and the morphometric studies, using the 
cellular changes and the expression of proteins respectively, in the PDL pancreas 
during the time periods pre- and post-PDL satisfied the classification of events into 
four landmarks as described earlier in the study. The relationship between the 
expression of these proteins, and the cellular and observable changes that take place 
during the PDL were statistically established. 
 
4.1.1. Cellular changes in PDL pancreas 
 
 The first landmark in this study covers the time periods 6 to 24 hours post-PDL. This 
period was characterized by a progressive granulation of acinar cells and subsequent 
acinar cell death (apoptosis).  This event which is thought to be due to the effect of 
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duct ligation procedure is well documented (Abe et al. 1995; Scoggins et al. 2000; 
Page et al. 2000; Yasuda et al. 1999). Another important element of the event shown 
in this study is that the islets of Langerhans remain unaffected at this stage, a fact 
which has rarely been reported (Page et al. 2000). Interestingly, the observation of 
fibroblast mitotic cells at this early hour post-PDL, suggests that mesenchymal 
replication precedes endocrine formation (Puri et al. 2010). This latest evidence 
emphasizes a plausible implication of extracellular signaling pathways in the cell fate 
specification. 
 
The programmed cell death that takes place in the first landmark is an ongoing 
process (Kerr 1993) sanctioned by cellular atrophy as was observed a decade ago by 
Auer and Kleiner (1918). This observation is in line with the second landmark of 36 
and 60 hours post-PDL. The data showed a high degree of necrotic appearance of the 
acinar cells which were remarkably atrophied and shapeless. The increase in the 
number of infiltrated mononuclear macrophages within the ductal epithelium and the 
adjoining acinar is a characteristic feature of cellular death (Walker 1987).  
 
The increase in the activity of the macrophages will therefore lead to a higher rate of 
acinar deletion (Abe et al. 1995; Edstrom et al. 1968) observed in the third landmark 
at 72 hours post-PDL of this study. This event was designated landmark of total 
pancreatic acinar cell death, characterized by the increase in numbers of infiltrated 
macrophages. The presence of these macrophages indicates the occurrence of a 
complex process of cellular degeneration and regeneration (Yamaguchi et al. 1993).   
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 Between 84 to 120 hours post-PDL, which corresponds to the fourth landmark, the 
acinar cells were progressively replaced by a rapid glandular remodeling of the 
pancreas. Walker (1987) had noted that the acinar cell deletion occurs without 
disruption of the underlying basement membrane, allowing the remodeling of the 
endocrine pancreas to take place. Page et al (2000) reported a similar observation 
from 84 hours post-PDL with evidence of ductal compartment evagination (Bouwen 
et al. 1994; Larsson 1998; Page et al. 2000) forming ovoid and/ or kidney shaped 
islets of Langerhans. This endocrine remodeling is a direct consequence of the 
increase in the beta cell mass (Scaglia et al. 1997; Walker 1987). Although the 
morphological changes showed evidence of neogenesis from duct (Wang et al. 1995), 
Solar et al (2009) postulated that, the duct cells do not contribute in the formation of 
new islets cell following PDL , and that  the pancreatic exocrine duct cells give rise to 
beta cells during embryogenesis only. Studies on cell proliferation kinetics (Teta et al. 
2007) and lineage tracing (Dor et al. 2004), support this opinion and further suggested 
that most of the newly formed beta cells originate from the pre-existing beta cells. 
This evidence warrant a study that will establish the level of similarity between PDL 
tissues and foetal tissues as they show the same efficacy as a promising therapeutic 
option for the treatment of DM (Page et al. 2000). 
 
4.1.2. Evaluation of transcription factors involved in PDL pancreas 
 
The morpho-immunofluorescent evaluation of caspase3, Pdx1, Ngn3, NeuroD and 
Pax6 was successively demonstrated. This will help in tracing the lineage of beta cells 
in PDL pancreas. 
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4.1.2.1. Caspase3 evaluation 
  
The immunohistofluorescent analysis of caspase3 expression showed a pulsatile 
profile at 6 hours, 24 hours and 72 hours post-PDL. This result contrasted with its 
morphological and morpho-immunological description, in which caspase3 reaction 
was observed only at 6 hours post-PDL. However, the three modes of caspase3 
expression curve suggested that apoptosis is an ongoing process of programmed cell 
death (Kerr 1993). The amount of caspase3 expression, significantly and positively 
correlated to that of Ngn3 which is a proendocrine factor and marker for islet cell 
precursors. Caspase3 was therefore the first gene to be expressed at 6 hours post-PDL, 
presumably because of its role in apoptosis (Bock et al. 2003; Kassem et al. 2000; 
Scaglia et al. 1997). This suggests that apoptosis is in part involved in triggering cell 
proliferation (Scoggins et al. 2000) in PDL pancreas. 
 
4.1.2.2. Pdx1 evaluation 
 
The profile of Pdx1 expression was similar to that of caspase3 expression with its 
highest expression occurring also at 6 hours post-PDL as observed for caspase3, and 
also concurred with its immunofluorescent evaluation. However, Pdx1 expression did 
not correlate with any other expression in the study. In mature differentiated cells, 
Pdx1 expression is specific to insulin-secreting cells and it is the first gene to be 
expressed in the endocrine lineage (Guz et al. 1995). These findings emphasize the 
importance of Pdx1expression in maintaining the balance between neogenesis, 
proliferation and apoptosis which is critical to sustain the integrity of beta cell mass 
(Finegood et al. 1995). Disruption of Pdx1 gene results in agenesis of the pancreas, 
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underscoring the critical implication of Pdx1 transcription factor in the development 
of the human and rodent pancreas (Habener et al. 2005; Jonsson et al. 1994; Offield et 
al. 1996; Stoffers et al. 1997b). The fact that Pdx1 expression had not correlated with 
any of the endocrine developmental transcription factors in this study, might be an 
indication of the presence of other progenitors such as duct and acinar cells (Gu et al. 
2002). 
 
4.1.2.3. Ngn3 evaluation 
 
The study showed a positive correlation between Ngn3 expression and caspase3 
expression as well as insulin expression. The highest expression of Ngn3 was 
observed at 36 hours post-PDL, concurrent with the immunofluorescent evaluation. 
The expression of Ngn3  revealed an islet cell precursor population (Schwitzgebel et 
al. 2000) where islet expressing cells increase greatly when islet differentiation is at 
its peak (Gradwohl et al. 2000). This is evident with the observation of a positive 
correlation between the insulin expression and Ngn3 expression in the study; although 
there is no evidence that Ngn3 drives insulin-producing beta cells. In addition, the 
correlation between caspase3 and Ngn3 supports the opinion by Scoggins et al (2000) 
that there is a direct link between acinar cell apoptosis and duct-like epithelial cell 
proliferation. Interestingly, as duct-like cells differentiate, they downregulate Ngn3, 
bud-off the epithelium and form aggregation of proto-islet structures (Pictet and 
Rutter 1972; Schwitzgebel et al 2000). 
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4.1.2.4.   NeuroD evaluation 
 
The expression of NeuroD occurred later in the time post-PDL: its highest expression 
being observed at 108 hours post-PDL, while its reaction in morpho-
immunofluorescent evaluation was described at 120 hours post-PDL. Expression of 
NeuroD did not correlate with any other expression in the study. This data contradicts 
Mutoh et al (1997) who observed a co-expression of NeuroD with Ngn3 and Pdx1 
during pancreatic beta cell development.  Although NeuroD expression in the study 
did not correlate with other transcription factor and, the fact that its expression occurs 
during recapitulation of foetal neogenesis (Lee et al. 2006), might highlight a 
plausible similarity between PDL tissue and foetal tissue. Furthermore, the  fact that 
NeuroD expression occurred later than  Ngn3 expression supports previous reports, 
that indicated the involvement of NeuroD-positive cells in the differentiation of cells 
expressing Ngn3 (Jensen et al. 2000a; Mutoh et al. 1997; Naya et al. 1997; 
Schwitzgebel et al. 2000) and Pdx1 (Mutoh et al. 1997). 
 
4.1.2.5.   Pax6 evaluation  
 
Pax6 gene is expressed early and occurred throughout the pancreas development until 
the endocrine cells are fully formed (Dohrmann et al. 2000; Sander et al. 1997; Sosa-
Pineda et al. 1997; St-Onge et al. 1997). This finding was concurrent with the 
immunofluorescent evaluation that showed immunoreaction at 84 hours post-PDL, 
and with the Pax6 expression observed throughout the time period post-PDL. In 
addition there was a positive correlation between Pax6 and insulin expression with 
their highest expression common at 84 hours post-PDL, while the early expression of 
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Pax6 occurred at 12 hours post-PDL. Inactivation of Pax6 gene leads to incomplete 
and malformed islets (St-Onge et al. 1997); but the exocrine component will tend to 
be normal (Dohrmann et al. 2000; Sander et al. 1997; Sosa-Pineda et al. 1997).  
However, co-expression of Pax6 with Pax4 is necessary for endocrine cell 
differentiation. These findings showed the importance of transcription factor Pax4 in 
the maturation of endocrine cells (Dohrmann et al. 2000; Sander et al. 1997; Sosa-
Pineda et al. 1997; St-Onge et al. 1997). Although Pax4 was not included in this 
study, it is important to note that Pax4 is expressed exclusively during embryogenesis 
and strongly but transiently in beta cells precursors (Wang et al. 2004). This 
information further gives room for speculation on the origin of beta cells in PDL 
pancreas as having the same efficacy as foetal tissue (Page et al. 2000). 
 
The immunofluorescent evaluation and the morphological assessment of the PDL 
pancreas revealed that there was no homeodomain protein expressed at 72 hours post-
PDL. At this period, a morphological assessment showed an increased in acinar 
deletion rate (Abe et al. 1995; Edstrom et al. 1968; Page et al. 2000) due to an 
increased in mononuclear phagocytic activities (Walker 1995). Furthermore, when 
data based on the expression by time and morphological changes are considered, an 
infradian rhythm of 72 hours post-PDL is observed. Further studies extending up to 
216 hours post-PDL are perhaps needed to confirm these findings. 
 
The differences in the timing of expression of different transcription factors as 
revealed by the immunofluorescent analysis of protein expression and the pattern of 
cellular changes suggest that some of the protein expression may have overlapped 
(Sommers et al. 1996b; Huang et al. 2000); suggesting that reactivation of the 
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program of embryonic differentiation in adult pancreatic ducts (Pierreux et al. 2006). 
However, there is convincing evidence that there is a relationship between cellular 
changes and protein synthesis in the remodelling of PDL pancreas. This is therefore a 
unique finding not previously reported. 
 
4.2.  Insulin expression and its variations when co-expressed with other                      
transcription factors 
 
The highest expression of insulin in this study was observed at 84 hours post-PDL; 
the same time was observed in the immunofluorescent evaluation. There was a 
significant and positive correlation between Ngn3, Caspase3 and insulin expression. 
This is logical as insulin expression requires a mature state of beta cells (Schwitzgebel 
et al. 2000). Previously, it was revealed that early insulin-expressing cells have low 
insulin levels (Pictet and Rutter 1972) and these cells do not co-express transcription 
factor Pdx1 (Oster et al. 1998; Pang et al. 1994). This is demonstrated by the low 
levels of insulin expression in the first mode of the insulin expression curve and, the 
non correlation between insulin and Pdx1expression in the study.  
 
When insulin was expressed at the same time with the other assessed products, the 
efficiency of co-expression index was observed between insulin and Ngn3 (optimal or 
high efficiency); insulin with Pdx1, insulin with NeuroD and insulin with Pax6 (good 
or medium efficiency) and insulin with caspase3 (low or fair efficiency).  Indeed the 
highest efficiency of co-expression of insulin with Pdx1, Ngn3 and NeuroD occurred 
at 12 hours post-PDL. These findings confirmed the dependency of the islet of 
Langerhans development on the sequential cascade of transcription factors activation 
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phases (Schwitzgebel 2001). The highest efficiency of co-expression of insulin with 
Pax6 occurred differently at 24 hours, and probably may be due to the extent and span 
of Pax6 function throughout the endocrine development until the endocrine cells reach 
maturity (Dohrmann et al. 2000; Sander et al. 1997; Sosa-Pineda et al. 1997; St-Onge 
et al. 1997). 
 
Furthermore, the cellular and morphological changes observed in the pancreas during 
differentiation process may also be dependent on sequential alteration in transcription 
factors (Jensen 2004; Kim and McDonald 2002; Lyttle et al. 2008; Peshavaria and 
Stein 1997; Sander and German 1997; Servitja and Ferrer 2004; Stoffers et al. 1997). 
The highest co-expression of Ngn3, Pdx1 and NeuroD with insulin at early stage of 
endocrine cell lineage in the PDL pancreas is in agreement with many studies 
(Collombat et al. 2006; Gradwohl et al. 2000; Johannasen et al. 2007; Naya et al. 
1995; Schwitzgebel 2001). However, this study further enlightens previous suggestion 
that duct ligated pancreatic tissues obtained at 84 hours post-PDL and used for 
transplantation yielded 50% success rate (Page et al. 2000). We therefore propose an 
early transplantation using 12 to 24 hours post-PDL harvested pancreatic tissues. This 
suggestion has not been reported in the literature. 
 
4.3.  Recapitulation of endocrine development in PDL pancreas 
 
The present study was conducted to describe the cellular mechanism involved in the 
recapitulation of endocrine development in PDL pancreas. The qualitative evaluation 
of the endocrine developmental transcription factors across the time periods post-PDL 
from 6 to 120 hours helped in mapping out the pattern of cellular neogenesis in the 
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PDL model of laboratory animals.  It is therefore necessary to highlight the elements 
of embryonic development in comparison with data from this study. 
 
4.3.1. Comparison between embryonic development and development in PDL 
pancreas 
 
The transcription factors evaluation data in this study corroborate and expand many of 
the previous investigations on foetal development, which suggest that the molecular 
events of homeodomain protein expression precede the visible developing pancreas 
(Hebrok et al. 1998; Gu et al. 2003; Lyttle et al. 2008; Murtaugh 2007; Schwitzgebel 
et al. 2001; Solar et al. 2009).  During foetal pancreas development, the transcription 
factor Pdx1 is the first gene to be expressed in the region destined to become the 
future pancreas (Hebrok et al. 1998; Lammert et al. 2001; Ohlsson et al. 1993). 
Similarly in the PDL pancreas, Pdx1 was the first to be expressed. This was observed 
at the first landmark of morphological changes and was characterized by the presence 
of mitotic fibroblastic cells (mesenchyme) within a healthy basement membrane. As 
development continues, the pancreatic epithelium proliferates, expand and branch 
towards the adjacent mesenchyme whose signals dictate the fate of cells toward an 
endocrine or an exocrine pancreas (Guz et al. 1995; Miralles et al. 1998a, 1998b). 
Hence, all Pdx1-positive cells destined to become endocrine pancreas also express the 
transcription factor Ngn3 (Gradwohl et al. 2000; Gu et al. 2002). In contrast with the 
embryonic development, Pdx1 expression in PDL pancreas did not correlate with 
Ngn3 expression. However, both Pdx1 and Ngn3 co-expression with insulin were 
positive at the first landmark. During the embryonic development of the pancreas, 
beta cell specific genes are regulated by NeuroD as it acts downstream of Ngn3 and, 
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together with Pdx1 (Naya et al. 1995).  This observation is in line with the events in 
the PDL pancreas, although there was no correlation of expression between NeuroD 
and Ngn3 in the study. Nevertheless, NeuroD co-expression with insulin was 
observed at the third landmark, establishing a distinct similarity between the events 
that took place in the PDL model to that of the embryonic development. Other 
similarities include the mesenchymal cells within the healthy acinar basement 
membrane and the early presence of Pdx1-expressing cells. Consequently, these 
findings show that PDL tissues might have the same efficacy as foetal tissue in term 
of beta cell transplantation (Page et al. 2000).  
 
4.3.2. Origin of the newly formed beta cells in PDL pancreas  
 
The histological data in this study showed evidence of mesenchymal cell division at 
the first landmark. The pre-existing islet cells were not also affected at this early stage 
and remained unaffected through to the fourth landmark, exhibiting a highly 
vascularised network of supply to the islets. Also, the fourth landmark was 
characterized by the budding of cells from the ductal epithelium, a histological 
evidence of duct-induced neogenesis (Wang et al. 1995). The presumptive 
centroacinar cells observed in this study have been shown to have a precursor capacity 
for new cells from adult cells following activation of the Notch pathway (Miyamoto et 
al, 2003).  
 
In the PDL model of laboratory rats, the beta cell mass increased by two-fold in a 
short period of time (Wang et al. 1995). Proliferation of the pre-existing beta cells 
does not account for this observable rapid beta cell mass increase (Wang et al. 1995). 
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Bouwens and Rooman (2005) have described this increase as a result of physiological 
condition of high insulin demand. However, absence of transient hyperglycemia in 
PDL model of rats rules out a plausible physiological reaction in this model of 
laboratory rats (Wang et al. 1995; Xu et al. 2008). Based on this evidence, the PDL 
model exhibits production of new beta cells rather than its replacement (Murtaugh and 
Kopinke 2008). The question on the origin of newly formed beta cells in PDL 
pancreas has to be supported by its evaluation of transcription factors involved in 
endocrine development. 
 
The fact that Pdx1 expression did correlate with the expression of Ngn3 might be an 
indication that the Pdx1-expressing cells did not give rise directly to the islet cells, but 
rather to the duct or acinar cells. Convincing evidence from rodent studies of normal 
foetal pancreatic development (Bonner-Weir and Sharma 2002; Bouwens and Blay 
1996; Gu et al. 2002; Slack 1995; Solar et al. 2009), as well as from few human 
studies (Castaing et al. 2005; Piper et al. 2004; Sarkar et al. 2008), have shown 
neogenesis of islet cells to derive from duct or acinar cells. However, duct cells after 
PDL have no evidence of neogenesis of beta cell after PDL (Solar et al. 2009; Xu et 
al. 2008). Recent study has demonstrated transdifferentiation of acinar cells into beta 
cells in vitro (Baeyens et al. 2010). Therefore, it is most likely that the newly formed 
beta cells in this study are derived from the centroacinar cells, since the Ngn3 
expression was observed at the second landmark and, had peaked at 36 hours post-
PDL. So far, the precise lineage of acinar or centroacinar cells has yet been 
elucidated. There is a possible cell-to-cell interaction between pre-existing 
mesenchymal cells and the pre-existing islet cells that might induce the “facultative  
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stem cell” capacity of the pre-existing beta cells as suggested in the case of the liver 
(Michalopoulos 2007) (Figure 26). This combination of mesenchymal cells with pre-
existing beta cells warrants future investigation. 
 
 
Figure 24. Scheme indicating the possible source of beta cells in PDL model. 
 
4.4. Implications of the study  
  
The present data on beta cell development in PDL pancreas and, the co-expression of 
insulin with caspase3, Pdx1, Ngn3, NeuroD and Pax6 will have implications in the 
pathophysiology of the pancreas such as diabetes mellitus management.  
 
4.5. Strength and limitations of the study 
 
To carry out the sectioning and staining of the PDL tissues in the present study, a 
complete laboratory was set up from scratch in the department of Anatomy, Histology 
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and Embryology at the Walter Sisulu University with limited funding and without any 
outside assistance. 
 
Despite its strength from rigorous methodology, this study had some limitations to 
some degree:  
The first limitation was the poor standard of equipments used which could not 
digitally separate the fluorescent colour images to reflect dual expression of proteins, 
and the inadequate technical support received for this work that required high 
technical manoeuvre offered elsewhere. 
 
The second limitation was the lack of optimization and method controls which could 
have helped in excluding possible false positive results of expression. This might 
probably explain the higher variability (systematic error or bias in measurement) of 
expression at critical times.  
 
The third limitation was the fact that the study did not assess Nk2.2, Pax4 and Nk6.1 
transcription factors which are specific for the lineage of beta cell development. 
Indeed Ngn3 may not represent a sustained stem cell population or a transient state 
through endogenous progenitor cells process. Potential genetic alterations of these 
cells were not considered.  
 
The strength of the study is based on the use of the expression pattern of transcription 
factors and the definition of the time-related efficiency of the expression of each 
protein profile according to the sequence of cellular lineage after PDL. This approach 
helped to categorize the present result in morphological changes as landmarks to each 
http://scholar.sun.ac.za
86 
 
target protein expression. Also, its strength resides in the use of PDL tissues preserved 
in Bouin’s fluid for immunohistofluorescent study not reported in the literature.  
 
4.6.  Conclusion 
 
This study provides strong evidence of connection between morphological changes in 
the PDL pancreas and the protein synthesis necessary for the lineage of endocrine cell 
development. Furthermore, these findings indicate that the optimal efficiency of co-
expression of insulin and other assessed homeodomain proteins occur between 12 
hours and 24 hours after PDL.  
 
4.7.  Recommendations and perspectives of the study 
 
From this study, we recommend the following for further research in the lineage 
analysis of endocrine development in the pancreas: 
i) to apply the present results in the development of an animal model that will 
produce PDL islets for transplantation under the renal capsule (Du Toit et 
al. 1998) and by injection in the liver segment (Keymeulen et al. 1998);  
 
ii) to perform islet transplantation between 12 hours and 24 hours after PDL, as 
later transplantation at 84 hours post-PDL showed 50% failure (Page et al. 
2004); 
iii) to develop translational studies to apply the present information on beta cell 
neogenesis as a potential therapy for diabetes mellitus in humans. 
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     Appendix 
Appendix 1 
Bouin’s fluid preparation 
• Picric Acid (standard aqueous solution) 75ml 
• Formalin (40% aqueous Formaldehyde) 20ml 
• Glacial Acetic Acid          5ml 
 
Appendix 2 
Tissue processing protocol: 
Materials:  
1. Tissue processor  
2. 70%, 80%, 95%, 99% ethanol  
3. Paraffin wax (Paraplast; melting point 58°C)  
4. Xylenes, Reagent Grade (Sigma)  
5. Embedding moulds  
Method:  
1. Fix tissue overnight in Bouin’s at room temperature  
2. Place the tissue in the tissue processor and process with the times and 
temperatures described in below.  
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3. Embed the specimen in paraffin and block. 
Station solution Concentration Time(min) Temp (°C) 
1 Ethanol 70 30 40 
2 Ethanol 80 30 40 
3 Ethanol 95 45 40 
4 Ethanol 95 45 40 
5 Ethanol 100 45 40 
6 Ethanol 100 45 40 
7 Xylenes 100 45 40 
8 Xylenes 100 45 58 
9 Paraffin  30 58 
10 Paraffin  30 58 
11 Paraffin  30 58 
12 Paraffin  30 58 
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Appendix 3 
Table 1: Slides in groups corresponding to the types of staining procedures used in 
the study for groups 0 and 5 hours pre-PDL, 6 and 12 hours post-PDL 
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Table 2: Slides in groups corresponding to the types of staining procedures used in 
the study for groups 24 hours, 36 hours, 48 hours and 60 hours post-PDL 
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Table 3: Slides in groups corresponding to the types of staining procedures used in 
the study for groups 72 hours, 84 hours, 96 hours and 120 hours post-PDL 
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 12D 12D1 12D2 12D3 12D4 12D5 12D6 12D7 12D8 12D9 12D10 12D11 12D12 
 12E 12E1 12E2 12E3 12E4 12E5 12E6 12E7 12E8 12E9 12E10 12E11 12E12 
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 13E 13E1 13E2 13E3 13E4 13E5 13E6 13E7 13E8 13E9 13E10 13E11 13E12 
 13F 13F1 13F2 13F3 13F4 13F5 13F6 13F7 13F8 13F9 13F10 13F11 13F12 
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Appendix 4 
Haematoxylin and Eosin staining protocol: 
Materials: 
1. Autostainer 
2. xylenes 
3. plastic rack 
4. 99% and 95% ethanol 
5. 1% acid alcohol 
6. Harris haematoxylin and eosin solutions 
7. 0.2% ammonia 
8. Glass slides 
9. Cover slipper 
10. DPX mounting solution 
Method: 
1. Place the tissue in the autostainer with the times programmed as described 
below 
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2. Mount cover slip on glass slides using DPX. 
Station Solution Concentration Time 
1 Xylene  10 min 
2 Xylene  10 min 
3 Ethanol 99% 5 min 
4 Ethanol 99% 5 min 
5 Ethanol 95% 2 min 
6 Ethanol 70% 2 min 
7 Distilled 
water 
 5 sec 
8 Haematoxylin  8 min 
9 Running 
water 
 5 min 
10 Ethanol 1% acid 
alcohol 
30 sec 
11 Running 
water 
 1min 
12 Ammonia 0.20% 45 sec 
13 Running 
water 
 5 min 
14 Ethanol 95% 10 dips 
15 Eosin  45 sec 
16 Ethanol 95% 5 min 
17 Ethanol 95% 5 min 
18 Xylene  5 min 
19 Xylene  5 min 
 
 
Appendix 5 
Deparaffinization and Rehydration Protocol: 
Materials: 
1. Autostainer with incorporated oven 
2. xylene 
3. 99%, 95% and 80% ethanol 
4. plastic rack 
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Method: 
1. Place rack in autostainer with oven on at 65°C overnight 
2. Proceed with deparaffinization as shown below 
3. Replacement of xylene and alcohol bath solutions after every 156 slides 
processed. 
 
Station Solution Concentration Time 
1 In oven At 65°C 12 hrs 
2 Allow to 
cool 
 1 hr 
3 Xylene  5 min 
4 Xylene  5 min 
5 Tap off   
6 Ethanol 99% 3 min 
7 Ethanol 99% 3 min 
8 Ethanol 95% 3 min 
9 Ethanol 95% 3 min 
10 Ethanol 80% 3 min 
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Appendix 6 
Table 4: Record of the measurements of single gene expressions indicating the 
counts, the areas and the expression index per period of times pre- and post-PDL 
PstPDL InsCount InsArea InsIndex PdxCount PdxArea PdxIndex NgnCount NgnArea NgnIndex 
0 28.000 10.156 2.757 153.000 21.878 6.993 350.000 45.814 7.640 
0 28.000 10.156 2.757 47.000 6.478 7.255 326.000 53.942 6.044 
0 52.000 13.297 3.911 50.000 4.338 11.525 183.000 19.605 9.334 
0 66.000 35.712 1.848 14.000 2.082 6.725 929.000 204.106 4.552 
0 227.000 88.743 2.558 137.000 21.770 6.293 595.000 105.132 5.660 
0 17.000 7.717 2.203 198.000 36.534 5.420 497.000 46.528 10.682 
5 66.000 35.712 1.848 14.000 2.082 6.725 350.000 45.814 7.640 
5 227.000 88.743 2.558 137.000 21.770 6.293 326.000 53.942 6.044 
5 52.000 13.297 3.911 50.000 4.338 11.525 595.000 105.132 5.660 
5 28.000 10.156 2.757 153.000 21.878 6.993 497.000 46.528 10.682 
5 28.000 10.156 2.757 47.000 6.478 7.255 183.000 19.605 9.334 
5 17.000 7.717 2.203 198.000 36.534 5.420 929.000 204.106 4.552 
6 2.000 0.141 14.156 4.000 0.549 7.292 4.000 0.220 18.162 
6 2.000 0.141 14.156 5.000 0.370 13.520 12.000 1.367 8.777 
6 1.000 0.046 21.877 1.000 0.017 60.162 1.000 0.170 5.869 
6 1.000 0.299 3.342 6.000 0.519 11.551 7.000 1.184 5.911 
6 6.000 1.500 4.000 1.000 0.017 60.162 2.000 0.154 13.008 
6 16.000 0.819 19.545 1.000 0.004 240.649 35.000 4.367 8.014 
12 1.000 0.253 3.945 2.000 0.220 9.081 5.000 0.877 5.703 
12 1.000 0.253 3.945 3.000 0.295 10.168 9.000 0.332 27.073 
12 5.000 0.125 40.108 5.000 0.939 5.324 5.000 0.283 17.695 
12 4.000 0.137 29.170 2.000 0.087 22.919 3.000 0.175 17.189 
12 3.000 0.345 8.698 3.000 1.101 2.724 3.000 0.395 7.599 
12 5.000 0.440 11.351 6.000 0.594 10.097 6.000 1.068 5.618 
24 2.000 0.141 14.156 8.000 1.517 5.275 6.000 1.421 4.222 
24 2.000 0.141 14.156 7.000 1.646 4.254 9.000 1.824 4.934 
24 8.000 0.199 40.108 2.000 0.220 9.081 2.000 3.495 0.572 
24 11.000 0.420 26.209 2.000 0.652 3.066 4.000 0.204 19.645 
24 5.000 0.366 13.673 1.000 0.004 240.649 1.000 0.881 1.135 
24 2.000 0.249 8.022 7.000 0.586 11.947 8.000 0.486 16.455 
36 254.000 31.993 7.939 266.000 19.343 13.751 535.000 24.505 21.833 
36 1.000 0.253 3.945 1282.000 42.552 30.128 951.000 39.905 23.832 
36 773.000 38.762 19.942 621.000 28.290 21.951 731.000 31.685 23.071 
36 219.000 18.330 11.948 793.000 34.548 22.953 1 349.000 54.407 24.795 
36 180.000 15.778 11.408 216.000 18.126 11.917 1 439.000 59.456 24.203 
36 86.000 12.175 7.063 600.000 17.910 33.501 172.000 17.104 10.056 
48 1.000 0.253 3.945 56.000 12.641 4.430 371.000 29.836 12.435 
48 254.000 31.993 7.939 142.000 31.261 4.542 187.000 31.652 5.908 
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48 862.000 48.344 17.830 311.000 82.119 3.787 145.000 17.947 8.079 
48 812.000 39.659 20.474 233.000 39.344 5.922 642.000 35.101 18.290 
48 1568.00 77.972 20.110 539.000 31.037 17.366 1 065.000 59.601 17.869 
48 1200.00 87.659 13.689 235.000 20.162 11.656 692.000 44.945 15.397 
60 388.000 31.880 12.170 76.000 12.819 5.928 852.000 51.723 16.473 
60 2293.00 149.707 15.317 628.000 47.359 13.260 404.000 30.119 13.414 
          
60 160.000 15.998 10.001 503.000 35.504 14.167 641.000 45.182 14.187 
60 124.000 17.756 6.984 584.000 52.977 11.024 305.000 30.098 10.134 
60 885.000 35.109 25.207 700.000 48.897 14.316 231.000 23.703 9.746 
60 474.000 31.303 15.142 257.000 26.632 9.650 1 782.000 85.045 20.954 
72 2293.00 149.707 15.317 672.000 40.910 16.426 132.000 17.149 7.697 
72 388.000 31.880 12.170 686.000 41.966 16.347 824.000 38.616 21.338 
72 283.000 27.368 10.341 423.000 45.327 9.332 125.000 13.680 9.138 
72 167.000 19.169 8.712 10.000 11.236 0.890 112.000 16.514 6.782 
72 281.000 33.135 8.480 477.000 36.776 12.971 623.000 34.424 18.098 
72 158.000 19.788 7.985 292.000 31.905 9.152 667.000 37.490 17.791 
84 1059.00 34.623 30.587 966.000 46.291 20.868 569.000 27.767 20.492 
84 1989.00 57.511 34.585 3497.000 63.620 54.967 776.000 37.540 20.671 
84 2315.00 72.387 31.981 1026.000 50.904 20.156 962.000 52.915 18.180 
84 2481.00 86.449 28.699 1013.000 46.375 21.844 150.000 14.901 10.066 
84 2752.00 113.526 24.241 947.000 47.147 20.086 222.000 21.010 10.566 
84 2071.00 98.184 21.093 725.000 39.722 18.252 378.000 45.190 8.365 
96 1989.00 57.511 34.585 456.000 27.521 16.569 322.000 23.162 13.902 
96 1059.00 34.623 30.587 17.000 8.743 1.944 366.000 22.847 16.020 
96 166.000 11.178 14.850 1062.000 50.808 20.902 96.000 17.640 5.442 
96 548.000 21.405 25.602 22.000 9.017 2.440 375.000 49.952 7.507 
96 337.000 18.280 18.436 97.000 11.311 8.576 86.000 14.228 6.044 
96 401.000 21.845 18.357 85.000 5.369 15.832 829.000 78.903 10.507 
108 230.000 11.594 19.838 85.000 14.802 5.743 1 085.000 227.509 4.769 
108 237.000 25.111 9.438 50.000 9.736 5.135 1 140.000 264.019 4.318 
108 220.000 31.814 6.915 20.000 10.384 1.926 846.000 235.962 3.585 
108 48.000 12.878 3.727 789.000 57.457 13.732 407.000 112.591 3.615 
108 7.000 8.477 0.826 87.000 12.329 7.056 431.000 154.316 2.793 
108 98.000 17.814 5.501 150.000 21.180 7.082 279.000 82.556 3.380 
120 237.000 25.111 9.438 273.000 19.460 14.029 91.000 12.042 7.557 
120 230.000 11.594 19.838 65.000 11.764 5.525 82.000 10.135 8.091 
120 187.000 23.333 8.015 81.000 7.999 10.126 123.000 21.812 5.639 
120 102.000 12.022 8.485 87.000 13.784 6.312 87.000 13.887 6.265 
120 72.000 12.541 5.741 265.000 26.009 10.189 62.000 6.084 10.191 
120 111.000 11.452 9.692 268.000 53.667 4.994 295.000 81.691 3.611 
 
 
 
 
 
http://scholar.sun.ac.za
133 
 
PstPDL NeDCount NeDArea NeDIndex PaxCount PaxArea PaxIndex CaspCount CaspArea CaspIndex 
0 351.000 35.413 9.912 110.000 61.820 1.779 386.000 85.269 4.527 
0 1580.000 278.052 5.682 40.000 7.201 5.555 27.000 6.341 4.258 
0 1 205.000 161.642 7.455 214.000 94.532 2.264 64.000 11.245 5.692 
0 281.000 36.293 7.742 112.000 44.642 2.509 167.000 18.454 9.049 
0 272.000 37.083 7.335 104.000 38.720 2.686 77.000 19.410 3.967 
0 146.000 12.608 11.580 561.000 241.25 2.325 280.000 54.141 5.172 
5 351.000 35.413 9.912 104.000 38.720 2.686 77.000 19.410 3.967 
5 1 580.000 278.052 5.682 40.000 7.201 5.555 27.000 6.341 4.258 
5 272.000 37.083 7.335 214.000 94.532 2.264 64.000 11.245 5.692 
5 146.000 12.608 11.580 112.000 44.642 2.509 167.000 18.454 9.049 
5 1 205.000 161.642 7.455 110.000 61.820 1.779 386.000 85.269 4.527 
5 281.000 36.293 7.742 561.000 241.256 2.325 280.000 54.141 5.172 
6 11.000 0.109 100.678 3.000 0.503 5.967 1.000 0.058 17.189 
6 2.000 0.382 5.232 2.000 1.296 1.543 51.000 0.964 52.901 
6 1.000 0.054 18.511 13.000 1.122 11.587 1.000 0.382 2.616 
6 6.000 1.085 5.532 10.000 0.569 17.566 13.000 0.515 25.229 
6 7.000 0.648 10.798 14.000 1.961 7.138 3.000 0.486 6.170 
6 22.000 1.060 20.762 5.000 0.465 10.743 9.000 0.627 14.343 
12 3.000 0.661 4.541 4.000 0.474 8.444 2.000 0.798 2.507 
12 7.000 0.399 17.547 3.000 0.199 15.041 5.000 0.877 5.703 
12 3.000 0.270 11.107 9.000 0.881 10.216 6.000 0.494 12.134 
12 1.000 0.066 15.041 4.000 0.233 17.189 2.000 0.125 16.043 
12 10.000 0.324 30.852 5.000 0.199 25.068 3.000 0.432 6.942 
12 2.000 1.267 1.578 1.000 0.046 21.877 8.000 2.427 3.297 
24 8.000 0.744 10.755 6.000 0.287 20.926 5.000 0.341 14.674 
24 7.000 0.175 40.108 4.000 0.657 6.092 5.000 0.677 7.382 
24 20.000 1.130 17.695 17.000 4.168 4.079 1.000 0.357 2.798 
24 7.000 1.172 5.974 14.000 0.665 21.057 9.000 0.183 49.224 
24 5.000 0.661 7.568 5.000 0.274 18.231 4.000 0.997 4.011 
24 4.000 0.150 26.739 23.000 2.202 10.443 3.000 0.129 23.289 
36 2 208.000 110.447 19.991 252.000 22.855 11.026 768.000 36.738 20.905 
36 473.000 35.321 13.391 67.000 16.618 4.032 648.000 29.333 22.091 
36 239.000 17.902 13.351 123.000 10.206 12.052 258.000 19.460 13.258 
36 211.000 18.787 11.231 1269.00  51.797 24.499 46.000 11.540 3.986 
36 1 473.000 44.180 33.341 1049.00  49.508 21.189 771.000 48.440 15.917 
36 2 137.000 67.758 31.539 81.000 10.522 7.698 21.000 9.333 2.250 
48 178.000 19.385 9.182 120.000 22.942 5.231 777.000 46.150 16.836 
48 576.000 37.204 15.482 272.000 33.568 8.103 858.000 59.614 14.393 
48 402.000 44.060 9.124 194.000 25.302 7.667 597.000 53.713 11.115 
48 286.000 23.424 12.210 337.000 38.508 8.751 265.000 33.347 7.947 
48 80.000 18.201 4.395 68.000 13.231 5.139 263.000 29.994 8.768 
48 70.000 19.593 3.573 49.000 11.265 4.350 473.000 44.052 10.737 
60 418.000 35.882 11.649 379.000 43.142 8.785 411.000 36.717 11.194 
60 312.000 36.264 8.603 570.000 47.729 11.942 123.000 18.296 6.723 
60 494.000 28.398 17.395 767.000 50.430 15.209 62.000 15.338 4.042 
http://scholar.sun.ac.za
134 
 
60 812.000 44.945 18.067 744.000 46.117 16.133 265.000 25.045 10.581 
60 237.000 36.447 6.503 964.000 59.842 16.109 33.000 13.871 2.379 
60 262.000 57.025 4.594 569.000 41.504 13.709 58.000 17.224 3.367 
72 872.000 47.409 18.393 560.000 38.330 14.610 529.000 31.743 16.665 
72 628.000 41.205 15.241 283.000 18.978 14.912 1 535.000 79.103 19.405 
72 1 039.000 62.884 16.522 465.000 28.008 16.603 296.000 28.390 10.426 
72 1 044.000 41.982 24.868 498.000 32.716 15.222 662.000 38.616 17.143 
72 530.000 30.725 17.250 547.000 43.757 12.501 74.000 11.922 6.207 
72 1 206.000 61.999 19.452 352.000 33.588 10.480 652.000 40.387 16.144 
84 341.000 28.377 12.017 629.000 42.564 14.778 438.000 42.934 10.202 
84 390.000 34.648 11.256 775.000 38.072 20.356 274.000 31.735 8.634 
84 536.000 48.340 11.088 93.000 10.800 8.611 281.000 32.209 8.724 
84 281.000 31.286 8.982 1061.00 42.896 24.734 334.000 32.109 10.402 
84 457.000 37.307 12.250 826.000 50.617 16.319 164.000 18.188 9.017 
84 465.000 31.232 14.888 2393.00 128.19 18.668 635.000 57.258 11.090 
96 23.000 11.843 1.942 125.000 12.587 9.931 33.000 11.926 2.767 
96 56.000 11.033 5.076 122.000 15.799 7.722 34.000 9.553 3.559 
96 392.000 20.432 19.185 117.000 18.168 6.440 82.000 11.132 7.366 
96 504.000 32.699 15.413 13.000 9.350 1.390 115.000 12.321 9.334 
96 307.000 20.465 15.001 164.000 22.207 7.385 71.000 11.016 6.445 
96 441.000 35.836 12.306 178.000 23.067 7.717 69.000 10.164 6.789 
108 55.000 6.075 9.053 5.000 0.096 52.315 0.000 0.000 0.000 
108 195.000 17.282 11.283 365.000 23.836 15.313 49.000 14.656 3.343 
108 178.000 15.309 11.627 130.000 16.069 8.090 36.000 15.363 2.343 
108 51.000 9.092 5.609 173.000 26.985 6.411 84.000 36.751 2.286 
108 45.000 3.835 11.733 603.000 97.943 6.157 867.000 247.680 3.500 
108 1.000 0.004 240.649 376.000 64.463 5.833 236.000 37.370 6.315 
120 211.000 19.730 10.694 812.000 141.542 5.737 80.000 12.570 6.364 
120 75.000 4.870 15.400 805.000 156.58 5.141 30.000 5.061 5.927 
120 21.000 1.321 15.892 1357.00 501.96 2.703 24.000 1.737 13.817 
120 97.000 7.081 13.699 1296.00 317.82 4.078 24.000 9.416 2.549 
120 121.000 6.765 17.886 1304.00 370.24 3.522 61.000 8.639 7.061 
120 511.000 45.548 11.219 1284.00 257.66 4.983 45.000 3.968 11.339 
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Table 6: Record of measurements of the co-expression of genes indicating the counts, 
the areas and the expression index per period of times pre- and post-PDL 
PstPDL PdxInsCnt PdxInsArea PdxInsIndex NgnInsCnt NgnInsArea NgnInsIndex 
0 1 683.000 369.143 4.559 383.000 94.685 4.045 
0 1 277.000 276.863 4.612 675.000 266.940 2.529 
0 1 500.000 325.590 4.607 721.000 207.875 3.468 
0 1 408.000 441.518 3.189 828.000 461.156 1.795 
0 2 208.000 551.716 4.002 835.000 248.370 3.362 
0 1 065.000 360.570 2.954 915.000 311.835 2.934 
0 190.000 5 959.647 0.032 2 226.000 1 504.425 1.480 
0 217.000 5 930.941 0.037 2 267.000 2 079.524 1.090 
0 226.000 5 949.669 0.038 2 450.000 2 282.699 1.073 
0 152.000 5 954.922 0.026 2 554.000 1 314.012 1.944 
0 19.000 5 989.071 0.003 2 934.000 1 769.309 1.658 
0 146.000 5 961.882 0.024 3 009.000 1 065.675 2.824 
5 1 065.000 360.570 2.954 915.000 311.835 2.934 
5 2 208.000 551.716 4.002 835.000 248.370 3.362 
5 1 408.000 441.518 3.189 828.000 461.156 1.795 
5 1 500.000 325.590 4.607 721.000 207.875 3.468 
5 1 277.000 276.863 4.612 675.000 266.940 2.529 
5 1 683.000 369.143 4.559 383.000 94.685 4.045 
5 146.000 5 961.882 0.024 3 009.000 1 065.675 2.824 
5 19.000 5 989.071 0.003 2 934.000 1 769.309 1.658 
5 152.000 5 954.922 0.026 2 554.000 1 314.012 1.944 
5 226.000 5 949.669 0.038 2 450.000 2 282.699 1.073 
5 217.000 5 930.941 0.037 2 267.000 2 079.524 1.090 
5 190.000 5 959.647 0.032 2 226.000 1 504.425 1.480 
6 357.000 71.926 4.963 106.000 15.861 6.683 
6 22.000 1.442 15.257 30.000 5.074 5.913 
6 107.000 24.239 4.414 152.000 44.006 3.454 
6 69.000 6.009 11.483 14.000 0.594 23.560 
6 16.000 1.679 9.531 590.000 76.252 7.737 
6 488.000 66.167 7.375 157.000 19.032 8.249 
6 1 263.000 39.664 31.843 6 011.000 260.450 23.079 
6 6.000 0.561 10.696 1 258.000 28.490 44.156 
6 802.000 90.476 8.864 3 095.000 1 368.576 2.261 
6 2 816.000 151.910 18.537 5 153.000 169.259 30.445 
6 3 573.000 152.238 23.470 622.000 24.762 25.119 
6 2 299.000 217.852 10.553 378.000 5.622 67.232 
12 16.000 7.550 2.119 71.000 4.953 14.334 
12 90.000 7.796 11.545 71.000 4.899 14.492 
12 44.000 2.913 15.105 57.000 5.273 10.809 
12 16.000 1.513 10.578 16.000 1.006 15.911 
12 56.000 4.962 11.287 31.000 3.245 9.552 
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12 52.000 3.565 14.585 61.000 4.908 12.430 
12 571.000 36.534 15.629 507.000 8.111 62.505 
12 382.000 14.868 25.693 4 727.000 102.307 46.204 
12 217.000 5.144 42.182 173.000 3.395 50.958 
12 111.000 2.098 52.895 2 247.000 65.660 34.222 
12 502.000 11.299 44.430 817.000 23.241 35.153 
12 2 795.000 95.392 29.300 8 632.000 1 028.089 8.396 
24 389.000 45.884 8.478 40.000 8.411 4.756 
24 1 554.000 229.147 6.782 124.000 9.699 12.785 
24 731.000 101.367 7.211 89.000 6.832 13.028 
24 982.000 113.534 8.649 210.000 23.532 8.924 
24 262.000 29.848 8.778 51.000 4.608 11.067 
24 164.000 12.670 12.944 88.000 14.731 5.974 
24 2 051.000 62.963 32.575 26.000 0.698 37.243 
24 1 190.000 49.362 24.107 2 211.000 50.817 43.509 
24 1 337.000 46.200 28.939 6 624.000 255.251 25.951 
24 1 640.000 39.111 41.932 840.000 16.626 50.524 
24 4 539.000 331.985 13.672 1 931.000 40.291 47.926 
24 6 325.000 739.474 8.553 2 124.000 65.224 32.565 
36 6 575.000 837.846 7.848 5 627.000 1 204.849 4.670 
36 7 260.000 492.642 14.737 4 611.000 755.456 6.104 
36 10 428.000 883.119 11.808 3 837.000 1 547.808 2.479 
36 7 091.000 974.044 7.280 87.000 5.547 15.683 
36 4 279.000 178.704 23.945 3 833.000 1 953.299 1.962 
36 8 934.000 1 763.982 5.065 4 298.000 1 430.604 3.004 
36 16.000 5 991.884 0.003 1.000 5 998.437 0.000 
36 8 250.000 687.315 12.003 1.000 5 998.437 0.000 
36 2 961.000 5 067.327 0.584 1.000 5 998.437 0.000 
36 305.000 5 951.897 0.051 5 289.000 5 043.583 1.049 
36 1.000 5 998.437 0.000 1.000 5 998.437 0.000 
36 2 901.000 5 423.867 0.535 1.000 5 998.437 0.000 
48 2 528.000 236.938 10.669 1 798.000 549.397 3.273 
48 5 051.000 467.780 10.798 2 768.000 972.315 2.847 
48 5 236.000 321.983 16.262 1 883.000 772.074 2.439 
48 2 183.000 471.063 4.634 761.000 102.435 7.429 
48 2 242.000 479.145 4.679 2 958.000 777.987 3.802 
48 4 141.000 495.817 8.352 2 847.000 1 092.332 2.606 
48 1.000 5 998.354 0.000 1.000 5 998.437 0.000 
48 145.000 5 977.706 0.024 1.000 5 998.437 0.000 
48 4 348.000 4 590.808 0.947 1.000 5 998.437 0.000 
48 983.000 5 801.620 0.169 1.000 5 998.437 0.000 
48 888.000 5 780.452 0.154 1.000 5 998.437 0.000 
48 3 443.000 5 097.641 0.675 1.000 5 998.437 0.000 
48 1 859.000 899.741 2.066 3 332.000 585.034 5.695 
60 4 114.000 771.471 5.333 3 957.000 401.136 9.864 
60 4 348.000 820.721 5.298 3 581.000 176.772 20.258 
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60 4 783.000 1 167.042 4.098 1 788.000 66.749 26.787 
60 4 965.000 1 037.435 4.786 4 902.000 237.379 20.651 
60 5 042.000 300.017 16.806 1 493.000 68.693 21.734 
60 916.000 5 876.147 0.156 1.000 5 998.080 0.000 
60 710.000 5 811.044 0.122 14.000 5 993.887 0.002 
60 20.000 5 989.553 0.003 1.000 5 998.437 0.000 
60 515.000 5 841.562 0.088 28.000 5 987.621 0.005 
60 4 963.000 4 577.137 1.084 1.000 5 998.437 0.000 
60 290.000 5 926.806 0.049 635.000 5 848.705 0.109 
60 7 911.000 2 742.160 2.885 5 499.000 869.269 6.326 
72 5 683.000 3 216.485 1.767 4 931.000 666.734 7.396 
72 5 853.000 3 154.008 1.856 5 532.000 1 222.650 4.525 
72 3 159.000 179.282 17.620 4 268.000 1 307.379 3.265 
72 2 011.000 108.265 18.575 4 473.000 989.149 4.522 
72 2 077.000 123.296 16.846 5 391.000 923.223 5.839 
72 1.000 5 998.437 0.000 5.000 5 995.205 0.001 
72 1.000 5 998.437 0.000 1.000 5 997.906 0.000 
72 1.000 5 998.437 0.000 1.000 5 998.425 0.000 
72 251.000 5 926.615 0.042 1.000 5 998.425 0.000 
72 715.000 5 795.474 0.123 1.000 5 998.433 0.000 
72 182.000 5 966.316 0.031 1.000 5 997.947 0.000 
72 3 028.000 756.632 4.002 5 843.000 1 301.047 4.491 
72 3 364.000 1 028.201 3.272 4 703.000 843.663 5.574 
84 2 529.000 300.080 8.428 5 372.000 665.691 8.070 
84 3 077.000 616.814 4.989 4 290.000 592.098 7.245 
84 3 191.000 592.834 5.383 4 380.000 691.600 6.333 
84 3 290.000 693.050 4.747 5 580.000 1 382.015 4.038 
84 1.000 5 998.437 0.000 61.000 5 985.335 0.010 
84 1.000 5 998.437 0.000 1.000 5 998.176 0.000 
84 1.000 5 998.396 0.000 1.000 5 998.334 0.000 
84 1.000 5 998.437 0.000 1.000 5 998.437 0.000 
84 1.000 5 998.437 0.000 1.000 5 998.437 0.000 
84 1.000 5 998.437 0.000 1.000 5 998.026 0.000 
84 3 270.000 239.739 13.640 3 077.000 1 337.718 2.300 
84 2 406.000 3 111.112 0.773 160.000 10.401 15.383 
96 2 298.000 163.109 14.089 155.000 10.542 14.703 
96 3 257.000 2 308.130 1.411 1 323.000 83.553 15.834 
96 4 288.000 525.420 8.161 1 754.000 145.253 12.075 
96 3 703.000 624.290 5.932 3 682.000 1 487.492 2.475 
96 1.000 5 998.437 0.000 1.000 5 998.437 0.000 
96 1.000 5 998.437 0.000 56.000 5 977.328 0.009 
96 43.000 5 983.844 0.007 1.000 5 998.429 0.000 
96 1.000 5 998.421 0.000 1.000 5 998.437 0.000 
96 1.000 5 998.421 0.000 1.000 5 998.437 0.000 
96 1.000 5 998.437 0.000 1.000 5 998.437 0.000 
96 1 184.000 108.590 10.903 2 685.000 747.465 3.592 
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96 1 107.000 106.932 10.352 2 676.000 690.083 3.878 
96 937.000 90.227 10.385 2 574.000 795.298 3.237 
108 642.000 82.248 7.806 3 417.000 998.361 3.423 
108 313.000 42.643 7.340 3 677.000 904.017 4.067 
108 778.000 63.707 12.212 3 110.000 769.497 4.042 
108 1 034.000 4 779.897 0.216 1.000 5 998.437 0.000 
108 1 348.000 4 794.773 0.281 1.000 5 998.437 0.000 
108 3 503.000 3 971.521 0.882 1.000 5 998.437 0.000 
108 4 092.000 3 531.624 1.159 1.000 5 998.437 0.000 
108 4 213.000 3 204.555 1.315 1.000 5 998.429 0.000 
108 4 652.000 3 404.880 1.366 1.000 5 998.437 0.000 
108 2 976.000 668.221 4.454 327.000 25.681 12.733 
108 5 109.000 1 863.583 2.741 203.000 13.372 15.181 
108 5 033.000 1 107.637 4.544 218.000 10.480 20.802 
120 2 271.000 403.213 5.632 121.000 6.615 18.291 
120 291.000 14.556 19.991 251.000 12.853 19.529 
120 699.000 26.886 25.999 154.000 8.194 18.793 
120 52.000 5 979.327 0.009 1 883.000 4 522.227 0.416 
120 6.000 5 994.822 0.001 2 253.000 4 374.776 0.515 
120 380.000 5 792.636 0.066 1 362.000 4 872.787 0.280 
120 679.000 5 633.828 0.121 4 478.000 3 549.256 1.262 
120 150.000 5 936.709 0.025 2 577.000 4 391.710 0.587 
120 162.000 5 923.723 0.027 3 335.000 3 675.306 0.907 
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PstPDL NeDInsCnt NeDInsArea NeDInsIndex PaxInsCnt PaxInsArea PaxInsIndex 
0 1 034.000 340.516 3.037 1 683.000 369.143 4.559 
0 2 190.000 467.049 4.689 1 277.000 276.863 4.612 
0 1 972.000 375.663 5.249 1 500.000 325.590 4.607 
0 1 367.000 207.904 6.575 1 408.000 441.518 3.189 
0 1 744.000 233.630 7.465 2 208.000 551.716 4.002 
0 1 271.000 301.484 4.216 1 065.000 360.570 2.954 
0 2 810.000 3 432.297 0.819 190.000 5 959.647 0.032 
0 4 050.000 3 679.615 1.101 217.000 5 930.941 0.037 
0 3 896.000 3 283.188 1.187 226.000 5 949.669 0.038 
0 5 379.000 2 916.638 1.844 152.000 5 954.922 0.026 
0 4 951.000 3 412.920 1.451 19.000 5 989.071 0.003 
0 3 770.000 3 242.319 1.163 146.000 5 961.882 0.024 
5 1 034.000 340.516 3.037 2 156.000 808.986 2.665 
5 2 190.000 467.049 4.689 1 838.000 700.085 2.625 
5 1 972.000 375.663 5.249 1 371.000 292.064 4.694 
5 1 367.000 207.904 6.575 2 309.000 318.596 7.247 
5 1 744.000 233.630 7.465 1 420.000 258.451 5.494 
5 1 271.000 301.484 4.216 363.000 69.840 5.198 
5 2 810.000 3 432.297 0.819 1.000 5 998.437 0.000 
5 4 050.000 3 679.615 1.101 1.000 5 998.437 0.000 
5 3 896.000 3 283.188 1.187 3 616.000 4 814.391 0.751 
5 5 379.000 2 916.638 1.844 3 590.000 4 773.884 0.752 
5 4 951.000 3 412.920 1.451 3 011.000 4 994.720 0.603 
5 3 770.000 3 242.319 1.163 5 733.000 2 653.421 2.161 
6 6.000 0.536 11.193 2 953.000 1 007.449 2.931 
6 45.000 8.581 5.244 418.000 33.750 12.385 
6 8.000 0.116 68.757 21.000 0.798 26.321 
6 69.000 3.395 20.324 695.000 71.012 9.787 
6 16.000 0.706 22.649 196.000 22.755 8.613 
6 5.000 0.723 6.915 122.000 43.998 2.773 
6 28.000 7.833 3.575 4 023.000 2 922.564 1.377 
6 28.000 3.428 8.167 119.000 6.458 18.428 
6 17.000 2.373 7.165 148.000 3.025 48.923 
6 31.000 5.390 5.752 1 108.000 5 627.200 0.197 
6 23.000 4.367 5.266 2 731.000 110.825 24.642 
6 27.000 2.975 9.075 3 225.000 3 158.824 1.021 
12 54.000 7.251 7.447 19.000 4.218 4.505 
12 5.000 0.058 85.946 53.000 15.816 3.351 
12 76.000 10.817 7.026 179.000 9.416 19.010 
12 6.000 0.170 35.217 13.000 2.975 4.369 
12 85.000 14.124 6.018 187.000 27.264 6.859 
12 18.000 0.316 56.996 239.000 17.095 13.980 
12 66.000 13.289 4.966 2 396.000 51.232 46.767 
12 26.000 3.096 8.399 242.000 70.509 3.432 
12 32.000 8.755 3.655 19.000 1.064 17.861 
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12 23.000 4.721 4.872 4 727.000 562.299 8.407 
12 35.000 5.223 6.701 1 207.000 23.287 51.832 
12 43.000 8.951 4.804 5 274.000 769.942 6.850 
24 50.000 10.235 4.885 157.000 11.340 13.845 
24 67.000 5.381 12.451 119.000 10.172 11.698 
24 3.000 0.141 21.234 241.000 20.918 11.521 
24 18.000 1.230 14.634 1 039.000 90.958 11.423 
24 19.000 2.020 9.408 147.000 30.085 4.886 
24 8.000 0.112 71.304 293.000 67.044 4.370 
24 35.000 13.904 2.517 6 508.000 1 382.954 4.706 
24 48.000 5.606 8.563 1 599.000 41.612 38.426 
24 26.000 5.855 4.441 2 812.000 76.846 36.593 
24 92.000 21.949 4.192 4 158.000 163.566 25.421 
24 58.000 13.592 4.267 3 167.000 113.422 27.922 
24 18.000 10.098 1.783 558.000 11.099 50.274 
36 535.000 21.961 24.361 3 554.000 2 285.038 1.555 
36 3 335.000 240.595 13.861 5 146.000 2 629.664 1.957 
36 371.000 12.840 28.893 3 414.000 280.308 12.179 
36 456.000 16.418 27.774 4 209.000 2 545.883 1.653 
36 1 886.000 78.475 24.033 6 420.000 2 274.297 2.823 
36 1 268.000 54.129 23.426 6 676.000 1 156.866 5.771 
36 200.000 48.485 4.125 1.000 5 997.723 0.000 
36 285.000 68.668 4.150 73.000 5 973.301 0.012 
36 194.000 67.659 2.867 105.000 5 980.253 0.018 
36 177.000 63.241 2.799 1.000 5 998.437 0.000 
36 163.000 42.389 3.845 1.000 5 998.433 0.000 
36 160.000 41.637 3.843 1.000 5 998.176 0.000 
48 2 527.000 159.294 15.864 3 717.000 417.990 8.893 
48 1 067.000 60.162 17.735 3 953.000 1 123.236 3.519 
48 3 831.000 654.155 5.856 5 905.000 775.477 7.615 
48 2 444.000 220.179 11.100 6 083.000 658.772 9.234 
48 3 664.000 1 292.491 2.835 4 546.000 391.989 11.597 
48 2 733.000 1 131.871 2.415 3 628.000 356.423 10.179 
48 1.000 5 997.972 0.000 188.000 5 952.092 0.032 
48 365.000 61.716 5.914 1.000 5 998.392 0.000 
48 1 982.000 105.564 18.775 1 785.000 5 602.812 0.319 
48 1.000 5 998.371 0.000 2 151.000 5 414.538 0.397 
48 406.000 5 934.215 0.068 1 701.000 5 689.960 0.299 
48 1 660.000 79.136 20.977 140.000 5 976.547 0.023 
48 2 730.000 1 069.976 2.551 7 954.000 666.177 11.940 
60 2 707.000 1 322.061 2.048 7 530.000 884.328 8.515 
60 2 300.000 1 561.363 1.473 1 911.000 124.521 15.347 
60 4 284.000 226.882 18.882 880.000 66.470 13.239 
60 4 137.000 229.080 18.059 3 344.000 244.513 13.676 
60 6 027.000 1 173.105 5.138 3 013.000 311.998 9.657 
60 46.000 5 989.906 0.008 1.000 5 998.047 0.000 
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60 4 728.000 4 661.633 1.014 1.000 5 998.039 0.000 
60 4 421.000 5 096.594 0.867 7 362.000 2 980.079 2.470 
60 108.000 29.300 3.686 4 716.000 4 725.078 0.998 
60 98.000 21.916 4.472 24.000 5 980.623 0.004 
60 811.000 5 904.080 0.137 308.000 5 943.636 0.052 
60 1 238.000 55.911 22.142 3 455.000 520.970 6.632 
72 6 015.000 989.888 6.076 4 077.000 776.807 5.248 
72 3 471.000 696.586 4.983 4 297.000 1 780.641 2.413 
72 4 908.000 457.421 10.730 5 414.000 387.747 13.963 
72 1 749.000 227.202 7.698 4 646.000 439.739 10.565 
72 4 113.000 296.361 13.878 4 902.000 648.633 7.557 
72 6 489.000 898.295 7.224 8.000 5 995.982 0.001 
72 11 122.000 2 235.984 4.974 1.000 5 998.359 0.000 
72 9 739.000 1 257.070 7.747 150.000 5 965.763 0.025 
72 9 331.000 2 119.831 4.402 12 868.000 1 777.665 7.239 
72 5 842.000 1 329.008 4.396 1 106.000 5 734.364 0.193 
72 609.000 5 797.793 0.105 593.000 5 842.588 0.101 
72 4 935.000 320.844 15.381 3 999.000 617.924 6.472 
72 5 155.000 422.544 12.200 3 135.000 1 820.940 1.722 
84 5 005.000 433.627 11.542 5 416.000 1 058.727 5.116 
84 443.000 12.495 35.453 3 826.000 1 734.515 2.206 
84 2 528.000 358.264 7.056 3 559.000 492.675 7.224 
84 2 720.000 1 164.541 2.336 4 534.000 1 549.774 2.926 
84 374.000 44.139 8.473 151.000 5 967.421 0.025 
84 421.000 45.203 9.314 54.000 5 980.902 0.009 
84 307.000 38.263 8.023 147.000 5 959.655 0.025 
84 121.000 28.627 4.227 138.000 5 968.265 0.023 
84 197.000 45.294 4.349 1 318.000 5 556.055 0.237 
84 1 281.000 103.682 12.355 10.000 5 995.512 0.002 
84 1 678.000 4 345.697 0.386 2 267.000 2 056.174 1.103 
84 396.000 57.395 6.900 2 611.000 2 700.078 0.967 
96 14.000 6.640 2.108 2 034.000 3 038.550 0.669 
96 1 429.000 265.665 5.379 2 898.000 262.336 11.047 
96 3 095.000 1 277.199 2.423 2 489.000 300.101 8.294 
96 2 650.000 462.316 5.732 3 761.000 618.938 6.077 
96 1.000 5 998.437 0.000 268.000 5 925.522 0.045 
96 6 309.000 3 004.359 2.100 91.000 5 955.724 0.015 
96 3 331.000 5 114.400 0.651 2.000 5 998.030 0.000 
96 1.000 5 998.437 0.000 468.000 5 810.006 0.081 
96 1.000 5 998.437 0.000 524.000 5 841.400 0.090 
96 1.000 5 998.437 0.000 1.000 5 998.030 0.000 
96 1 698.000 163.408 10.391 1 666.000 1 884.564 0.884 
96 2 665.000 270.979 9.835 1 534.000 2 148.470 0.714 
96 1 959.000 182.390 10.741 1 538.000 1 140.007 1.349 
108 1 799.000 152.521 11.795 1 361.000 1 088.447 1.250 
108 2 201.000 196.576 11.197 982.000 1 347.072 0.729 
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108 1 716.000 140.557 12.209 899.000 1 311.294 0.686 
108 273.000 5 912.649 0.046 1.000 5 998.413 0.000 
108 62.000 5 978.778 0.010 2.000 5 997.174 0.000 
108 241.000 5 894.972 0.041 3.000 5 995.824 0.001 
108 269.000 5 905.024 0.046 6.000 5 997.120 0.001 
108 408.000 5 887.641 0.069 4.000 5 997.577 0.001 
108 180.000 5 934.635 0.030 1.000 5 998.421 0.000 
108 2 337.000 261.231 8.946 3 203.000 662.632 4.834 
108 2 375.000 284.979 8.334 3 076.000 919.637 3.345 
108 3 322.000 831.824 3.994 2 965.000 1 331.427 2.227 
120 3 166.000 721.473 4.388 3 106.000 1 032.058 3.010 
120 2 662.000 699.744 3.804 3 367.000 686.883 4.902 
120 2 627.000 909.556 2.888 2 804.000 1 032.768 2.715 
120 1 398.000 170.464 8.201 1.000 5 998.437 0.000 
120 365.000 56.900 6.415 1.000 5 998.437 0.000 
120 1 616.000 265.241 6.093 1.000 5 998.437 0.000 
120 612.000 97.445 6.280 1.000 5 998.437 0.000 
120 979.000 195.708 5.002 1.000 5 998.437 0.000 
120 1 534.000 346.596 4.426 1.000 5 998.437 0.000 
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PstPDL CaspInsCnt CaspInsArea CaspInsIndex 
0 3 024.000 688.807 4.390 
0 2 888.000 576.287 5.011 
0 2 696.000 861.586 3.129 
0 2 627.000 680.276 3.862 
0 2 535.000 754.937 3.358 
0 2 299.000 1 006.793 2.283 
0 511.000 5 862.592 0.087 
0 406.000 5 848.115 0.069 
0 310.000 5 893.268 0.053 
0 201.000 5 937.245 0.034 
0 165.000 5 935.196 0.028 
0 102.000 5 967.056 0.017 
5 3 024.000 688.807 4.390 
5 2 888.000 576.287 5.011 
5 2 627.000 680.276 3.862 
5 2 535.000 754.937 3.358 
5 2 696.000 861.586 3.129 
5 2 299.000 1 006.793 2.283 
5 102.000 5 967.056 0.017 
5 201.000 5 937.245 0.034 
5 165.000 5 935.196 0.028 
5 511.000 5 862.592 0.087 
5 406.000 5 848.115 0.069 
5 310.000 5 893.268 0.053 
6 190.000 16.850 11.276 
6 294.000 28.165 10.438 
6 180.000 11.565 15.565 
6 271.000 14.411 18.805 
6 643.000 43.661 14.727 
6 533.000 37.274 14.299 
6 3 609.000 539.931 6.684 
6 1 409.000 208.985 6.742 
6 4 892.000 798.685 6.125 
6 5 800.000 1 440.831 4.025 
6 2 217.000 188.224 11.779 
6 5 098.000 594.093 8.581 
12 245.000 31.552 7.765 
12 65.000 9.150 7.104 
12 76.000 8.689 8.747 
12 163.000 28.984 5.624 
12 84.000 12.495 6.722 
12 206.000 18.438 11.173 
12 2 837.000 1 299.829 2.183 
12 2 325.000 1 553.584 1.497 
12 3 501.000 2 922.144 1.198 
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12 2 776.000 2 782.102 0.998 
12 4 043.000 1 659.664 2.436 
12 1 422.000 4 101.009 0.347 
24 361.000 24.218 14.906 
24 455.000 38.367 11.859 
24 498.000 44.687 11.144 
24 934.000 82.169 11.367 
24 730.000 61.064 11.955 
24 932.000 90.002 10.355 
24 3 844.000 645.811 5.952 
24 5 575.000 1 353.787 4.118 
24 2 619.000 140.773 18.604 
24 470.000 8.311 56.553 
24 2 468.000 184.148 13.402 
24 4 938.000 919.097 5.373 
36 5 035.000 1 572.861 3.201 
36 4 262.000 2 297.912 1.855 
36 2 631.000 118.280 22.244 
36 3 895.000 753.191 5.171 
36 3 095.000 2 238.066 1.383 
36 5 574.000 848.130 6.572 
36 1.000 5 998.437 0.000 
36 1.000 5 998.437 0.000 
36 3.000 5 995.396 0.001 
36 302.000 5 925.003 0.051 
36 7.000 5 997.299 0.001 
36 498.000 5 835.316 0.085 
48 3 235.000 300.961 10.749 
48 5 940.000 812.157 7.314 
48 6 076.000 801.590 7.580 
48 4 072.000 701.340 5.806 
48 2 539.000 602.246 4.216 
48 3 295.000 646.156 5.099 
48 2 270.000 5 057.379 0.449 
48 1 845.000 5 652.137 0.326 
48 842.000 5 772.702 0.146 
48 860.000 5 711.996 0.151 
48 1 195.000 5 683.647 0.210 
48 1 909.000 5 468.579 0.349 
48 4 338.000 601.523 7.212 
60 3 996.000 282.964 14.122 
60 6 029.000 1 703.645 3.539 
60 3 301.000 198.343 16.643 
60 6 760.000 824.627 8.198 
60 5 285.000 1 344.595 3.931 
60 2.000 5 996.007 0.000 
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60 1.000 5 998.437 0.000 
60 1.000 5 998.433 0.000 
60 62.000 5 981.994 0.010 
60 1.000 5 998.417 0.000 
60 1.000 5 998.437 0.000 
60 1 026.000 38.994 26.311 
72 865.000 62.244 13.897 
72 1 242.000 83.316 14.907 
72 2 727.000 329.193 8.284 
72 2 292.000 642.075 3.570 
72 638.000 79.718 8.003 
72 2 024.000 5 572.627 0.363 
72 2 965.000 5 263.650 0.563 
72 1 390.000 5 579.695 0.249 
72 372.000 5 893.343 0.063 
72 2 186.000 5 305.429 0.412 
72 2 229.000 5 121.539 0.435 
72 3 787.000 370.124 10.232 
72 5 241.000 744.947 7.035 
84 4 594.000 748.936 6.134 
84 5 052.000 1 047.828 4.821 
84 5 888.000 616.133 9.556 
84 4 148.000 1 001.237 4.143 
84 198.000 5 927.081 0.033 
84 228.000 5 952.719 0.038 
84 10.000 5 995.059 0.002 
84 204.000 5 931.955 0.034 
84 182.000 5 934.739 0.031 
84 273.000 5 920.901 0.046 
84 1 367.000 2 081.543 0.657 
84 2 000.000 1 224.957 1.633 
96 1 710.000 1 958.194 0.873 
96 2 620.000 1 428.880 1.834 
96 1 694.000 318.563 5.318 
96 327.000 15.708 20.818 
96 1.000 5 998.437 0.000 
96 1.000 5 998.437 0.000 
96 1.000 5 998.437 0.000 
96 1.000 5 998.437 0.000 
96 400.000 5 937.860 0.067 
96 4 282.000 4 145.447 1.033 
96 5 621.000 500.334 11.235 
96 5 544.000 446.430 12.419 
96 6 779.000 515.638 13.147 
108 9 081.000 646.256 14.052 
108 8 123.000 734.554 11.058 
http://scholar.sun.ac.za
146 
 
108 6 289.000 555.647 11.318 
108 1 362.000 5 055.514 0.269 
108 1 865.000 4 623.524 0.403 
108 4 771.000 1 614.648 2.955 
108 3 563.000 2 462.064 1.447 
108 3 451.000 2 556.359 1.350 
108 3 529.000 2 593.957 1.360 
108 3 043.000 278.538 10.925 
108 3 595.000 978.573 3.674 
108 4 031.000 692.460 5.821 
120 3 481.000 486.018 7.162 
120 2 585.000 210.784 12.264 
120 3 367.000 1 322.522 2.546 
120 1.000 5 998.437 0.000 
120 1.000 5 998.437 0.000 
120 1.000 5 998.437 0.000 
120 1.000 5 998.437 0.000 
120 1.000 5 998.437 0.000 
120 1.000 5 998.437 0.000 
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